Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier

The blood–brain barrier (BBB) is a tailored system of capillary endothelial cells intermixed with tight junctions and adherent junctions that regulates the transport of various materials and substances between the blood vasculature and the central nervous system (CNS). However, in cases of brain dis...

Full description

Saved in:
Bibliographic Details
Published inAdvanced functional materials Vol. 34; no. 19
Main Authors Beygi, Mohammad, Oroojalian, Fatemeh, Azizi‐Arani, Soheil, Hosseini, Seyed Samad, Mokhtarzadeh, Ahad, Kesharwani, Prashant, Sahebkar, Amirhossein
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc 01.05.2024
Subjects
Blood-brain barrier
Central nervous system
CNS disorders
drug delivery
Endothelial cells
multifunctional nanotheranostics
nanotechnology
Side effects
Signs and symptoms
Online AccessGet full text
ISSN1616-301X
1616-3028
DOI10.1002/adfm.202310881

Cover

Abstract The blood–brain barrier (BBB) is a tailored system of capillary endothelial cells intermixed with tight junctions and adherent junctions that regulates the transport of various materials and substances between the blood vasculature and the central nervous system (CNS). However, in cases of brain diseases, BBB's protective and regulatory effects hamper therapeutics from reaching affected sites in sufficient quantities. This has so far been a leading challenge in treating CNS diseases and disorders. For this problem to be overcome, recent research has sought to develop novel modalities to achieve efficient therapy and alleviate associated symptoms. Therefore, numerous strategies have operated in recent years to address the limitations of traditional and invasive methods, including poor brain penetration and serious side effects. As a desperately in‐demand technology, nanotheranostics has particularly shown promising results. Herein, this review reports recent advancements in CNS nanotheranostics and novel techniques and nanotechnology‐based strategies developed for treating neurodegenerative disorders. The study provides comprehensive data on the subject to be used for future studies for the therapy and management of CNS disorders and diseases. Brain nanotheranostics offer versatile and multifunctional platforms to traverse the blood‐brain barrier and blood–brain tumor barrier for the early diagnosis and treatment of CNS diseases and disorders.
AbstractList The blood–brain barrier (BBB) is a tailored system of capillary endothelial cells intermixed with tight junctions and adherent junctions that regulates the transport of various materials and substances between the blood vasculature and the central nervous system (CNS). However, in cases of brain diseases, BBB's protective and regulatory effects hamper therapeutics from reaching affected sites in sufficient quantities. This has so far been a leading challenge in treating CNS diseases and disorders. For this problem to be overcome, recent research has sought to develop novel modalities to achieve efficient therapy and alleviate associated symptoms. Therefore, numerous strategies have operated in recent years to address the limitations of traditional and invasive methods, including poor brain penetration and serious side effects. As a desperately in‐demand technology, nanotheranostics has particularly shown promising results. Herein, this review reports recent advancements in CNS nanotheranostics and novel techniques and nanotechnology‐based strategies developed for treating neurodegenerative disorders. The study provides comprehensive data on the subject to be used for future studies for the therapy and management of CNS disorders and diseases. Brain nanotheranostics offer versatile and multifunctional platforms to traverse the blood‐brain barrier and blood–brain tumor barrier for the early diagnosis and treatment of CNS diseases and disorders.
The blood–brain barrier (BBB) is a tailored system of capillary endothelial cells intermixed with tight junctions and adherent junctions that regulates the transport of various materials and substances between the blood vasculature and the central nervous system (CNS). However, in cases of brain diseases, BBB's protective and regulatory effects hamper therapeutics from reaching affected sites in sufficient quantities. This has so far been a leading challenge in treating CNS diseases and disorders. For this problem to be overcome, recent research has sought to develop novel modalities to achieve efficient therapy and alleviate associated symptoms. Therefore, numerous strategies have operated in recent years to address the limitations of traditional and invasive methods, including poor brain penetration and serious side effects. As a desperately in‐demand technology, nanotheranostics has particularly shown promising results. Herein, this review reports recent advancements in CNS nanotheranostics and novel techniques and nanotechnology‐based strategies developed for treating neurodegenerative disorders. The study provides comprehensive data on the subject to be used for future studies for the therapy and management of CNS disorders and diseases.
Author Azizi‐Arani, Soheil
Hosseini, Seyed Samad
Kesharwani, Prashant
Sahebkar, Amirhossein
Beygi, Mohammad
Mokhtarzadeh, Ahad
Oroojalian, Fatemeh
Author_xml – sequence: 1
  givenname: Mohammad
  surname: Beygi
  fullname: Beygi, Mohammad
  organization: Isfahan University of Technology (IUT)
– sequence: 2
  givenname: Fatemeh
  surname: Oroojalian
  fullname: Oroojalian, Fatemeh
  email: f.oroojalian@ut.ac.ir
  organization: North Khorasan University of Medical Sciences
– sequence: 3
  givenname: Soheil
  surname: Azizi‐Arani
  fullname: Azizi‐Arani, Soheil
  organization: Novosibirsk State University
– sequence: 4
  givenname: Seyed Samad
  surname: Hosseini
  fullname: Hosseini, Seyed Samad
  organization: Tabriz University of Medical Sciences
– sequence: 5
  givenname: Ahad
  surname: Mokhtarzadeh
  fullname: Mokhtarzadeh, Ahad
  email: mokhtarzadehah@tbzmed.ac.ir
  organization: Tabriz University of Medical Sciences
– sequence: 6
  givenname: Prashant
  orcidid: 0000-0002-0890-769X
  surname: Kesharwani
  fullname: Kesharwani, Prashant
  email: prashantdops@gmail.com
  organization: Jamia Hamdard
– sequence: 7
  givenname: Amirhossein
  surname: Sahebkar
  fullname: Sahebkar, Amirhossein
  email: amir_saheb2000@yahoo.com
  organization: Mashhad University of Medical Sciences
BookMark eNqFkM1OAjEUhRuDiYBuXU_ierC3HWi7BBQlAdlo4q4pnY6WDFNsZzTsfAff0CexBIOJiXF1b3LOd39OB7UqVxmEzgH3AGNyqfJi3SOYUMCcwxFqwwAGKcWEtw49PJ6gTggrjIExmrXRdN6UtS2aStfWVapM7lTl6mfjYwm11SEpnE8Wr8Zrt7bVUxK1ZFQ6l3--f4y8slUyUt5b40_RcaHKYM6-axc9TK7vx7fpbHEzHQ9nqabAIF0yoUzRH4AmmPE8UyzHGoslKaKeaYB-LgzLVUFppjNOGQEOBjIuoqxyQbvoYj93491LY0ItV67x8fQgKe4DJ1QIHl29vUt7F4I3hdx4u1Z-KwHLXVxyF5c8xBWB7Begba12odTxy_JvTOyxN1ua7T9L5PBqMv9hvwCga4JQ
CitedBy_id crossref_primary_10_1186_s12951_025_03204_5
crossref_primary_10_1186_s12951_024_02648_5
crossref_primary_10_1007_s12668_025_01896_5
crossref_primary_10_3390_ijms252413302
crossref_primary_10_1016_j_cclet_2024_109996
crossref_primary_10_1016_j_ijpharm_2024_124847
crossref_primary_10_2174_011574888X313112240510160102
crossref_primary_10_32628_IJSRST2512126
crossref_primary_10_1007_s12668_024_01677_6
crossref_primary_10_1016_j_ijbiomac_2024_138793
crossref_primary_10_1016_j_eurpolymj_2024_112924
crossref_primary_10_1002_smsc_202400095
crossref_primary_10_3390_cancers17040701
crossref_primary_10_1002_ddr_22244
crossref_primary_10_1016_j_ultrasmedbio_2025_02_015
crossref_primary_10_1002_adfm_202413847
crossref_primary_10_3390_ijms25137501
crossref_primary_10_1002_adfm_202401570
crossref_primary_10_1515_hmbci_2024_0005
crossref_primary_10_1016_j_jddst_2025_106724
Cites_doi 10.7150/ntno.38954
10.1016/j.apsb.2019.01.011
10.1038/s41598-020-75253-9
10.1016/j.biomaterials.2018.07.014
10.1016/j.jconrel.2019.01.005
10.1016/j.nano.2017.02.013
10.1126/sciadv.aay1344
10.1186/s13046-019-1180-5
10.1158/1078-0432.CCR-18-3643
10.1007/s12274-017-1815-9
10.1208/s12248-017-0176-3
10.1042/ETLS20190141
10.1177/0271678X16662042
10.3390/ma11050779
10.1533/9780857096258
10.1039/C8NR03828G
10.1039/D0NR04035E
10.1016/j.omto.2022.12.002
10.1039/C7TB01314K
10.1039/C9NR02866H
10.1002/smtd.202200289
10.1096/fasebj.2019.33.1_supplement.785.8
10.1021/acs.langmuir.9b01617
10.1021/acsami.1c00157
10.1021/acsami.9b12319
10.1021/acsnano.8b03785
10.1016/j.amjmed.2020.05.049
10.1016/j.msec.2018.10.094
10.1039/C8CS00162F
10.1038/s41467-018-04813-5
10.1016/j.expneurol.2019.113094
10.1155/2016/2847232
10.1155/2019/6341545
10.1016/j.jconrel.2018.10.034
10.3390/pharmaceutics15010236
10.1016/j.ijpharm.2017.12.010
10.1016/j.carbon.2016.10.096
10.1021/acsomega.8b00764
10.1016/j.nano.2019.102119
10.1177/0271678X17740031
10.1016/j.ultrasmedbio.2019.02.024
10.1016/j.ccr.2018.03.007
10.1002/adfm.202002560
10.3390/cancers13153690
10.1021/acsnano.8b06556
10.1021/acsami.6b15831
10.1007/s11010-021-04053-0
10.1007/s12035-023-03318-7
10.3390/ijms21051611
10.1002/tcr.202000104
10.3390/biomedicines9121834
10.1039/C9TB01042D
10.1016/j.jconrel.2017.05.013
10.1016/j.jconrel.2016.01.015
10.1002/jps.24329
10.1016/j.coelec.2018.03.017
10.1021/acsami.9b10787
10.1016/j.snb.2018.01.149
10.1093/nar/gkz757
10.3390/pharmaceutics15071833
10.1016/j.envres.2023.116563
10.1016/j.biomaterials.2015.02.083
10.1016/j.biopha.2018.10.167
10.1186/s12951-022-01746-6
10.1146/annurev-pathmechdis-012418-013109
10.1039/C3AY42207K
10.1088/1361-6528/ab0f46
10.1016/j.bioactmat.2020.08.017
10.1021/acs.nanolett.8b01818
10.1016/j.jconrel.2014.06.031
10.1016/j.arabjc.2018.03.019
10.1039/C5NR05649G
10.1002/mabi.201500091
10.1002/cnma.201700264
10.1177/0271678X18788769
10.1021/acsnano.7b07625
10.3390/ijms22031068
10.1016/B978-0-12-817901-7.00013-7
10.1016/j.jconrel.2019.05.005
10.1093/neuonc/noz167.011
10.1021/acs.jcim.8b00725
10.2147/IJN.S314895
10.1016/j.biomaterials.2020.119987
10.1021/acsami.9b07980
10.1039/C9NR03931G
10.1016/j.bioorg.2018.11.034
10.1038/s41377-022-00794-9
10.1016/j.biomaterials.2016.06.056
10.1002/adma.201800766
10.1096/fj.201701121R
10.3390/biomedicines8010013
10.1016/j.jconrel.2022.06.050
10.1016/j.pmatsci.2023.101190
10.3390/cancers13030503
10.1016/B978-0-12-812218-1.00014-2
10.1007/s12017-013-8261-y
10.1002/cmdc.201800262
10.1093/toxsci/kfq244
10.1016/j.ijpharm.2019.02.022
10.18632/aging.204573
10.3390/ijms15021812
10.1007/s11596-017-1783-z
10.3390/molecules25163731
10.1016/B978-0-08-102985-5.00001-2
10.1002/mds.27360
10.3390/pharmaceutics13040500
10.1016/j.jconrel.2017.04.033
10.3390/molecules25173814
10.1038/s41598-021-94175-8
10.2147/IJN.S239608
10.1002/adhm.201900543
10.1002/smll.202006484
10.1002/adfm.202003054
10.1080/10717544.2021.1937384
10.3389/fnmol.2021.618360
10.7150/ntno.54491
10.1159/000488821
10.1016/j.biomaterials.2019.04.026
10.1002/jbm.a.36145
10.3390/pharmaceutics12090890
10.1016/S1474-4422(19)30403-X
10.1016/j.jconrel.2017.05.019
10.1158/1538-7445.AM2018-CT013
10.1016/j.jcis.2021.11.019
10.1021/acs.nanolett.0c00495
10.1039/D0CC05878E
10.1039/C6MD00481D
10.1016/j.ijbiomac.2022.04.207
10.1021/acsnano.1c01669
10.1038/nm.3407
10.1080/17435390.2019.1621398
10.1186/s12951-020-00705-3
10.1021/acsnano.0c02249
10.1016/j.addr.2023.115115
10.1016/j.brainres.2022.147937
10.1016/j.jconrel.2020.10.043
10.3389/fonc.2020.563938
10.1016/j.expneurol.2019.03.017
10.4155/fmc-2018-0208
10.2217/nnm-2016-0410
10.1021/acsnano.8b05265
10.1021/acs.nanolett.2c01863
10.2147/DDDT.S218708
10.1016/j.jneumeth.2019.108478
10.3389/fneur.2023.1149963
10.1021/acsnano.9b01808
10.1016/j.jconrel.2017.08.027
10.1080/1061186X.2018.1497037
10.1016/j.mtbio.2023.100674
10.1158/1078-0432.CCR-16-2598
10.1021/nn406197c
10.1021/acsami.7b06510
10.1111/cns.13569
10.1002/adma.202106194
10.1039/D2BM01594C
10.1186/s12951-018-0340-7
10.3390/ijms21010022
10.4155/tde-2017-0075
10.1080/14737175.2019.1631161
10.3109/21691401.2014.953633
10.1016/j.colsurfb.2018.02.061
10.17219/acem/62915
10.1016/j.addr.2020.09.001
10.1016/j.mad.2023.111800
10.7150/thno.30977
10.3389/fmedt.2021.678593
10.3390/en13040892
10.12688/f1000research.14506.1
10.1016/j.nano.2016.04.008
10.1016/j.ejpb.2020.09.003
10.1016/j.biopha.2016.12.010
10.1016/j.xphs.2018.07.020
10.1016/j.jconrel.2022.06.026
10.1002/jps.23022
10.3390/pharmaceutics12010072
10.1007/s00775-020-01834-8
10.7150/thno.15217
10.1016/j.nano.2016.08.029
10.1016/j.cej.2021.133848
10.1002/adma.201902504
10.3390/nano8030178
10.1016/j.ijpharm.2020.119045
10.1021/mp3003946
10.3389/fimmu.2017.01335
10.2147/IJN.S123422
10.3390/pr10020426
10.1021/acsnano.9b00661
10.1002/adma.201802368
10.1002/adfm.202213292
10.1016/j.jddst.2022.103899
10.1016/j.actbio.2020.03.021
10.4028/www.scientific.net/JNanoR.48.18
10.1016/j.drudis.2017.11.010
10.1002/adma.201802591
10.1016/j.cbi.2016.05.020
10.1080/10717544.2019.1571123
10.7150/ntno.63158
10.3390/pharmaceutics11090481
10.1007/s12015-020-09966-9
10.1007/978-1-4939-8946-1_19
10.1016/j.biopha.2018.12.133
10.1002/advs.202102001
10.1002/ana.23648
10.1002/smll.201701921
10.1021/acsabm.0c01039
10.1016/j.biopha.2021.112117
10.2174/1567205018666210218160812
10.1016/j.jconrel.2016.01.031
10.1016/j.nano.2019.01.014
10.1021/acsami.2c12370
10.1002/adma.201903759
10.1016/j.brainresbull.2018.11.006
10.1007/s00702-016-1527-4
10.1039/D0BM00756K
10.1016/j.ymgme.2018.05.003
10.1080/17425247.2019.1614911
10.1002/cplu.201700078
10.3390/ijms21072586
10.1126/sciadv.abd0772
10.1073/pnas.1616070114
10.3390/pharmaceutics12020186
10.1016/j.chemphyslip.2018.01.007
10.1371/journal.pone.0219995
10.1039/C7BM01012E
10.1039/C9NR09713A
10.1007/s12192-018-0896-z
10.2147/IJN.S68429
10.3390/molecules27041372
10.1021/acsbiomaterials.8b01420
10.1039/C8CS00805A
10.1186/s12951-021-00798-4
10.3389/fmats.2019.00179
10.1007/s42247-019-00033-9
10.1016/j.coph.2018.11.006
10.1038/s41598-019-44569-6
10.3390/pharmaceutics10030139
10.1016/j.biomaterials.2018.03.004
10.1007/s11427-017-9292-7
10.3389/fnins.2018.00612
10.7150/thno.22482
10.1021/acsnano.3c03724
10.1080/17425247.2020.1698544
10.1016/j.mattod.2020.02.001
10.1016/j.addr.2022.114539
10.1016/j.mattod.2022.05.024
10.2217/nnm-2017-0022
10.1021/acs.bioconjchem.1c00321
10.1002/smll.201900669
10.1248/cpb.c19-00854
10.1038/s41467-019-11719-3
10.1007/s11064-022-03585-1
10.1073/pnas.2002016117
10.3389/fonc.2021.819329
10.1016/j.bmcl.2017.07.075
10.1021/acs.molpharmaceut.1c00224
10.1039/C7NR04445C
10.1021/acsami.0c03873
10.1016/j.actbio.2022.05.029
10.3390/mi13081279
10.1039/C9NR08194A
10.1158/1078-0432.CCR-19-3538
10.1517/17425241003777010
10.1016/j.biomaterials.2019.119342
10.1016/j.actbio.2018.10.012
10.7150/ntno.23125
10.1038/s41596-021-00635-w
10.1038/s41598-020-75125-2
10.4081/ejtm.2019.8209
10.1016/j.jconrel.2019.04.031
10.1016/j.bcp.2018.09.007
10.1007/s11910-017-0739-9
10.1038/s41568-019-0205-x
10.1007/s10571-017-0572-3
10.2147/IJN.S299448
10.1021/acs.langmuir.0c01496
10.1080/09205063.2017.1332470
10.1016/j.actbio.2018.04.029
10.1021/acs.analchem.9b02266
10.1007/s10876-020-01955-9
10.3233/JAD-180766
10.1039/C9NR00473D
10.1016/j.nano.2018.09.010
10.1039/C8NA00010G
10.1016/j.jconrel.2021.11.007
10.1021/acsami.8b18664
10.1101/cshperspect.a020412
10.1208/s12249-017-0812-3
10.1002/anie.201609231
10.1038/nnano.2017.133
10.1007/s13311-016-0448-0
10.1039/C7CS00053G
10.7150/thno.60851
10.1002/adfm.201909369
10.7150/thno.26249
10.1186/s13052-018-0563-0
10.1021/acs.molpharmaceut.0c00461
10.1007/s10571-017-0547-4
10.2147/IJN.S240953
10.15171/apb.2017.002
10.1016/j.jddst.2021.102867
10.1080/10717544.2019.1636420
10.1016/j.radonc.2021.04.021
10.3389/fnins.2018.01019
10.3390/pharmaceutics13010005
10.1021/acsami.7b03504
10.1039/C8DT03948H
10.1021/acs.nanolett.9b02841
10.1016/j.apsb.2020.11.023
10.4103/1735-5362.199041
10.1186/s12951-018-0356-z
10.1016/j.snb.2017.04.101
10.1002/smll.201703115
10.1080/10717544.2017.1402218
10.1016/j.nantod.2020.100965
10.1016/j.pdpdt.2017.12.014
10.3390/magnetochemistry8100131
10.1021/acsanm.2c03936
10.1021/nn501069c
10.1016/j.bcp.2023.115574
10.1186/s12951-020-00751-x
10.1016/j.addr.2021.113851
10.1007/s13239-020-00496-6
10.1371/journal.pone.0179131
10.2147/OTT.S287272
10.1016/j.addr.2022.114536
10.2174/1573409915666191212095340
10.3390/pharmaceutics11020065
10.1016/j.jconrel.2018.09.015
10.5772/intechopen.68523
10.1016/j.semcancer.2019.10.010
10.1016/j.nano.2018.05.008
10.1038/s41392-021-00724-y
10.1002/adfm.201909529
ContentType Journal Article
Copyright 2024 Wiley‐VCH GmbH
Copyright_xml – notice: 2024 Wiley‐VCH GmbH
DBID AAYXX
CITATION
7SP
7SR
7U5
8BQ
8FD
JG9
L7M
DOI 10.1002/adfm.202310881
DatabaseName CrossRef
Electronics & Communications Abstracts
Engineered Materials Abstracts
Solid State and Superconductivity Abstracts
METADEX
Technology Research Database
Materials Research Database
Advanced Technologies Database with Aerospace
DatabaseTitle CrossRef
Materials Research Database
Engineered Materials Abstracts
Technology Research Database
Electronics & Communications Abstracts
Solid State and Superconductivity Abstracts
Advanced Technologies Database with Aerospace
METADEX
DatabaseTitleList
Materials Research Database
CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1616-3028
EndPage n/a
ExternalDocumentID 10_1002_adfm_202310881
ADFM202310881
Genre reviewArticle
GrantInformation_xml – fundername: North Khorasan University of Medical Sciences, Bojnurd, Iran.
– fundername: Immunology Research Center, Tabriz University of Medical Sciences
GroupedDBID -~X
.3N
.GA
05W
0R~
10A
1L6
1OC
23M
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANLZ
AAONW
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ACAHQ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
EBS
F00
F01
F04
F5P
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
Q.N
Q11
QB0
QRW
R.K
RNS
ROL
RWI
RX1
RYL
SUPJJ
UB1
V2E
W8V
W99
WBKPD
WFSAM
WIH
WIK
WJL
WOHZO
WQJ
WRC
WXSBR
WYISQ
XG1
XPP
XV2
~IA
~WT
.Y3
31~
AANHP
AASGY
AAYXX
ACBWZ
ACRPL
ACYXJ
ADMLS
ADNMO
AEYWJ
AGHNM
AGQPQ
AGYGG
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
HF~
HVGLF
LW6
7SP
7SR
7U5
8BQ
8FD
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
JG9
L7M
ID FETCH-LOGICAL-c3171-b79aef561c2078d4a7d0c09b2fc314c115d9e7daf334c48372181e1489314ad93
IEDL.DBID DR2
ISSN 1616-301X
IngestDate Sun Jul 13 04:25:27 EDT 2025
Tue Jul 01 00:30:54 EDT 2025
Thu Apr 24 23:02:21 EDT 2025
Wed Jan 22 17:20:43 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 19
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3171-b79aef561c2078d4a7d0c09b2fc314c115d9e7daf334c48372181e1489314ad93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ORCID 0000-0002-0890-769X
PQID 3051823998
PQPubID 2045204
PageCount 49
ParticipantIDs proquest_journals_3051823998
crossref_primary_10_1002_adfm_202310881
crossref_citationtrail_10_1002_adfm_202310881
wiley_primary_10_1002_adfm_202310881_ADFM202310881
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-05-01
PublicationDateYYYYMMDD 2024-05-01
PublicationDate_xml – month: 05
  year: 2024
  text: 2024-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
PublicationTitle Advanced functional materials
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2021; 329
2017; 86
2017; 82
2021; 66
2020; 20
2019; 11
2019; 10
2019; 13
2019; 12
2019; 15
2019; 14
2020; 17
2019; 17
2020; 16
2019; 16
2019; 19
2020; 15
2020; 14
2020; 13
2016; 2016
2020; 12
2020; 11
2020; 10
2020; 19
2020; 18
2019; 21
2018; 212
2023; 211
2019; 26
2019; 25
2019; 27
2019; 29
2022; 608
2010; 7
2016; 44
2019; 31
2019; 30
2019; 33
2018; 107
2019; 35
2022; 1788
2019; 38
2020; 37
2020; 36
2020; 35
2017; 250
2020; 32
2017; 258
2016; 13
2016; 12
2016; 6
2019; 42
2020; 30
2019; 44
2022; 6
2022; 8
2019; 45
2019; 48
2017; 56
2020; 26
2017; 260
2020; 25
2020; 24
2020; 156
2020; 21
2017; 264
2019; 295
2017; 48
2017; 46
2020; 56
2016; 225
2016; 104
2020; 245
2018; 82
2016; 224
2017; 112
2017; 114
2013; 19
2020; 8
2023; 20
2020; 6
2020; 4
2020; 3
2021; 476
2017; 37
2023; 28
2019; 63
2013; 10
2018; 536
2019; 67
2020; 48
2020; 133
2018; 73
2014; 8
2017; 124
2014; 6
2021; 9
2021; 8
2021; 7
2021; 6
2021; 5
2023; 14
2023; 11
2021; 3
2012
2023; 17
2017; 26
2023; 15
2017; 28
2017; 27
2017; 24
2017; 23
2019; 303
2021; 340
2019; 304
2018; 61
2015; 7
2020; 109
2022; 433
2019; 84
2023
2022
2021
2017; 17
2020
2017; 13
2017; 12
2016; 256
2019
2018
2020; 117
2017
2020; 68
2016
2017; 18
2017; 105
2018; 59
2014; 189
2022; 210
2018; 166
2019; 91
2019; 2019
2019; 96
2018; 289
2021; 160
2022; 20
2020; 323
2022; 22
2018; 44
2020; 329
2022; 27
2018; 47
2019; 561
2018; 46
2018; 7
2018; 6
2018; 9
2018; 8
2018; 3
2018; 292
2018; 2
2018; 4
2010; 118
2020; 578
2022; 34
2014; 16
2014; 15
2018; 30
2019; 316
2018; 33
2018; 180
2018; 32
2018; 38
2019; 8
2019; 7
2019; 9
2019; 3
2012; 101
2019; 5
2019; 2
2019; 1
2015; 53
2019; 109
2021; 143
2018; 23
2018; 22
2018; 21
2018; 20
2023; 60
2018; 18
2022; 12
2022; 13
2019; 218
2022; 10
2022; 11
2018; 12
2018; 11
2022; 348
2018; 10
2022; 349
2018; 16
2022; 17
2019; 211
2018; 14
2018; 13
2017; 5
2021; 27
2017; 7
2018; 364
2017; 8
2021; 26
2021; 21
2021; 22
2015; 104
2023; 6
2018; 124
2021; 28
2017; 9
2012; 72
2021; 32
2021; 33
2019; 111
2015; 15
2018; 261
2015; 10
2022; 47
2019; 144
2021; 14
2021; 13
2021; 16
2021; 15
2021; 11
2018; 157
2021; 18
2021; 17
2021; 19
2022; 57
2021; 170
2021; 176
2022; 147
e_1_2_17_190_1
e_1_2_17_212_1
e_1_2_17_258_1
e_1_2_17_30_1
Schaich M. (e_1_2_17_197_1) 2019
e_1_2_17_235_1
e_1_2_17_53_1
e_1_2_17_99_1
e_1_2_17_7_1
e_1_2_17_318_1
e_1_2_17_76_1
e_1_2_17_152_1
e_1_2_17_175_1
e_1_2_17_198_1
e_1_2_17_15_1
e_1_2_17_38_1
e_1_2_17_310_1
e_1_2_17_333_1
e_1_2_17_103_1
e_1_2_17_126_1
e_1_2_17_149_1
e_1_2_17_261_1
Kwon Y. M. (e_1_2_17_283_1) 2019; 42
e_1_2_17_91_1
Kempe K. (e_1_2_17_133_1) 2021
Shetty K. (e_1_2_17_266_1) 2022; 12
e_1_2_17_284_1
e_1_2_17_200_1
e_1_2_17_223_1
e_1_2_17_246_1
e_1_2_17_269_1
e_1_2_17_41_1
Bender H. R. (e_1_2_17_328_1) 2016
e_1_2_17_64_1
e_1_2_17_87_1
e_1_2_17_329_1
e_1_2_17_208_1
e_1_2_17_164_1
e_1_2_17_306_1
e_1_2_17_26_1
e_1_2_17_49_1
e_1_2_17_187_1
e_1_2_17_141_1
e_1_2_17_321_1
e_1_2_17_115_1
e_1_2_17_344_1
e_1_2_17_138_1
e_1_2_17_272_1
e_1_2_17_295_1
e_1_2_17_213_1
e_1_2_17_236_1
e_1_2_17_54_1
e_1_2_17_77_1
e_1_2_17_31_1
e_1_2_17_259_1
e_1_2_17_6_1
e_1_2_17_319_1
e_1_2_17_174_1
e_1_2_17_16_1
e_1_2_17_39_1
e_1_2_17_334_1
e_1_2_17_151_1
e_1_2_17_311_1
e_1_2_17_125_1
e_1_2_17_148_1
e_1_2_17_102_1
e_1_2_17_92_1
e_1_2_17_262_1
e_1_2_17_285_1
e_1_2_17_201_1
e_1_2_17_247_1
e_1_2_17_224_1
e_1_2_17_42_1
e_1_2_17_88_1
e_1_2_17_307_1
e_1_2_17_65_1
Wang S.‐W. (e_1_2_17_253_1) 2018; 22
e_1_2_17_140_1
e_1_2_17_163_1
e_1_2_17_186_1
e_1_2_17_209_1
e_1_2_17_27_1
e_1_2_17_322_1
e_1_2_17_114_1
e_1_2_17_137_1
e_1_2_17_345_1
e_1_2_17_250_1
e_1_2_17_296_1
Di Pardo A. (e_1_2_17_144_1) 2017
e_1_2_17_273_1
Betzer O. (e_1_2_17_109_1) 2019
e_1_2_17_233_1
e_1_2_17_279_1
e_1_2_17_93_1
e_1_2_17_256_1
e_1_2_17_9_1
e_1_2_17_32_1
e_1_2_17_78_1
e_1_2_17_55_1
e_1_2_17_218_1
e_1_2_17_316_1
e_1_2_17_339_1
e_1_2_17_196_1
e_1_2_17_17_1
e_1_2_17_150_1
e_1_2_17_173_1
e_1_2_17_342_1
e_1_2_17_147_1
e_1_2_17_101_1
e_1_2_17_124_1
e_1_2_17_282_1
e_1_2_17_70_1
e_1_2_17_221_1
e_1_2_17_244_1
e_1_2_17_267_1
e_1_2_17_20_1
e_1_2_17_43_1
e_1_2_17_66_1
e_1_2_17_89_1
e_1_2_17_206_1
e_1_2_17_229_1
e_1_2_17_185_1
e_1_2_17_327_1
Chaudhary V. (e_1_2_17_80_1) 2018; 33
e_1_2_17_304_1
e_1_2_17_28_1
e_1_2_17_162_1
e_1_2_17_136_1
e_1_2_17_330_1
e_1_2_17_113_1
e_1_2_17_159_1
e_1_2_17_270_1
e_1_2_17_1_1
e_1_2_17_81_1
e_1_2_17_232_1
e_1_2_17_293_1
e_1_2_17_211_1
e_1_2_17_234_1
e_1_2_17_257_1
e_1_2_17_71_1
e_1_2_17_94_1
e_1_2_17_8_1
e_1_2_17_10_1
e_1_2_17_56_1
e_1_2_17_33_1
e_1_2_17_219_1
e_1_2_17_317_1
e_1_2_17_79_1
e_1_2_17_18_1
e_1_2_17_111_1
e_1_2_17_195_1
e_1_2_17_172_1
e_1_2_17_332_1
e_1_2_17_320_1
e_1_2_17_123_1
e_1_2_17_146_1
e_1_2_17_108_1
e_1_2_17_169_1
e_1_2_17_260_1
e_1_2_17_245_1
e_1_2_17_268_1
e_1_2_17_222_1
e_1_2_17_82_1
e_1_2_17_21_1
e_1_2_17_67_1
e_1_2_17_44_1
e_1_2_17_207_1
e_1_2_17_305_1
e_1_2_17_29_1
e_1_2_17_100_1
e_1_2_17_161_1
e_1_2_17_184_1
e_1_2_17_331_1
e_1_2_17_343_1
e_1_2_17_112_1
e_1_2_17_135_1
e_1_2_17_158_1
e_1_2_17_271_1
e_1_2_17_210_1
e_1_2_17_294_1
e_1_2_17_95_1
e_1_2_17_3_1
e_1_2_17_72_1
e_1_2_17_277_1
e_1_2_17_216_1
e_1_2_17_11_1
e_1_2_17_34_1
e_1_2_17_239_1
e_1_2_17_57_1
e_1_2_17_314_1
e_1_2_17_337_1
e_1_2_17_110_1
e_1_2_17_171_1
e_1_2_17_194_1
e_1_2_17_340_1
e_1_2_17_19_1
e_1_2_17_145_1
e_1_2_17_107_1
e_1_2_17_168_1
e_1_2_17_280_1
e_1_2_17_265_1
e_1_2_17_242_1
e_1_2_17_60_1
e_1_2_17_83_1
e_1_2_17_288_1
e_1_2_17_204_1
e_1_2_17_227_1
e_1_2_17_22_1
e_1_2_17_45_1
e_1_2_17_68_1
e_1_2_17_325_1
e_1_2_17_122_1
e_1_2_17_160_1
e_1_2_17_302_1
e_1_2_17_183_1
e_1_2_17_134_1
e_1_2_17_119_1
e_1_2_17_157_1
e_1_2_17_348_1
e_1_2_17_230_1
e_1_2_17_276_1
e_1_2_17_291_1
e_1_2_17_50_1
e_1_2_17_73_1
e_1_2_17_96_1
e_1_2_17_255_1
e_1_2_17_278_1
e_1_2_17_2_1
e_1_2_17_217_1
e_1_2_17_12_1
e_1_2_17_35_1
e_1_2_17_338_1
e_1_2_17_58_1
e_1_2_17_155_1
e_1_2_17_315_1
e_1_2_17_132_1
e_1_2_17_170_1
e_1_2_17_341_1
e_1_2_17_193_1
e_1_2_17_167_1
e_1_2_17_129_1
e_1_2_17_106_1
e_1_2_17_281_1
e_1_2_17_243_1
e_1_2_17_220_1
e_1_2_17_84_1
e_1_2_17_289_1
e_1_2_17_61_1
e_1_2_17_205_1
e_1_2_17_23_1
e_1_2_17_228_1
e_1_2_17_46_1
e_1_2_17_303_1
e_1_2_17_326_1
e_1_2_17_69_1
e_1_2_17_182_1
e_1_2_17_118_1
e_1_2_17_156_1
e_1_2_17_179_1
e_1_2_17_292_1
e_1_2_17_231_1
e_1_2_17_5_1
e_1_2_17_74_1
e_1_2_17_51_1
e_1_2_17_214_1
e_1_2_17_237_1
e_1_2_17_97_1
e_1_2_17_13_1
e_1_2_17_36_1
e_1_2_17_59_1
e_1_2_17_154_1
e_1_2_17_177_1
e_1_2_17_312_1
e_1_2_17_335_1
e_1_2_17_131_1
e_1_2_17_192_1
e_1_2_17_189_1
e_1_2_17_105_1
e_1_2_17_128_1
e_1_2_17_240_1
e_1_2_17_286_1
e_1_2_17_263_1
e_1_2_17_62_1
e_1_2_17_85_1
e_1_2_17_202_1
e_1_2_17_225_1
e_1_2_17_248_1
e_1_2_17_308_1
e_1_2_17_24_1
e_1_2_17_47_1
Al‐Musawi S. (e_1_2_17_121_1) 2018; 10
e_1_2_17_166_1
e_1_2_17_143_1
e_1_2_17_181_1
e_1_2_17_323_1
e_1_2_17_120_1
e_1_2_17_300_1
e_1_2_17_346_1
e_1_2_17_178_1
e_1_2_17_117_1
e_1_2_17_297_1
e_1_2_17_251_1
e_1_2_17_274_1
e_1_2_17_4_1
e_1_2_17_191_1
e_1_2_17_52_1
e_1_2_17_215_1
e_1_2_17_238_1
e_1_2_17_299_1
e_1_2_17_75_1
e_1_2_17_98_1
e_1_2_17_14_1
e_1_2_17_153_1
e_1_2_17_199_1
e_1_2_17_37_1
e_1_2_17_176_1
e_1_2_17_336_1
e_1_2_17_313_1
e_1_2_17_130_1
e_1_2_17_104_1
e_1_2_17_127_1
e_1_2_17_241_1
e_1_2_17_264_1
e_1_2_17_287_1
e_1_2_17_90_1
e_1_2_17_63_1
e_1_2_17_180_1
e_1_2_17_40_1
e_1_2_17_203_1
e_1_2_17_309_1
e_1_2_17_226_1
e_1_2_17_86_1
e_1_2_17_249_1
Xue X. (e_1_2_17_254_1) 2020; 26
e_1_2_17_25_1
e_1_2_17_165_1
e_1_2_17_188_1
e_1_2_17_48_1
e_1_2_17_301_1
e_1_2_17_324_1
e_1_2_17_142_1
e_1_2_17_290_1
e_1_2_17_347_1
e_1_2_17_116_1
e_1_2_17_139_1
e_1_2_17_298_1
e_1_2_17_275_1
e_1_2_17_252_1
References_xml – volume: 32
  start-page: 2014
  year: 2021
  publication-title: Bioconjugate Chem.
– volume: 8
  start-page: 4477
  year: 2018
  publication-title: Theranostics
– volume: 15
  start-page: 1833
  year: 2023
  publication-title: Pharmaceutics
– volume: 8
  start-page: 13
  year: 2020
  publication-title: Biomedicines
– volume: 13
  year: 2021
  publication-title: ACS Appl. Mater. Interfaces
– volume: 14
  year: 2019
  publication-title: PLoS One
– volume: 105
  start-page: 2851
  year: 2017
  publication-title: J. Biomed. Mater. Res., Part A
– volume: 66
  year: 2021
  publication-title: J Drug Deliv Sci Technol
– volume: 21
  start-page: 2586
  year: 2020
  publication-title: Int. J. Mol. Sci.
– volume: 12
  year: 2020
  publication-title: ACS Appl. Mater. Interfaces
– volume: 18
  start-page: 3227
  year: 2017
  publication-title: AAPS PharmSciTech
– volume: 258
  start-page: 121
  year: 2017
  publication-title: J. Controlled Release
– volume: 37
  start-page: 2185
  year: 2017
  publication-title: J. Cereb. Blood Flow Metab.
– volume: 12
  start-page: 890
  year: 2020
  publication-title: Pharmaceutics
– volume: 12
  year: 2017
  publication-title: PLoS One
– volume: 44
  start-page: 127
  year: 2018
  publication-title: Ital J Pediatr
– volume: 16
  start-page: 725
  year: 2020
  publication-title: Curr. Comput.‐Aided Drug Des.
– volume: 13
  start-page: 503
  year: 2021
  publication-title: Cancers
– volume: 38
  start-page: 231
  year: 2019
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 17
  start-page: 236
  year: 2019
  publication-title: Nanomed., Nanotechnol., Biol. Med.
– volume: 13
  start-page: 1645
  year: 2017
  publication-title: Nanomedicine
– volume: 16
  start-page: 32
  year: 2018
  publication-title: J. Nanobiotechnol.
– volume: 9
  start-page: 675
  year: 2019
  publication-title: Acta Pharm. Sin. B
– volume: 11
  year: 2021
  publication-title: Sci Rep
– volume: 26
  start-page: 29
  year: 2021
  publication-title: J Biol Inorg Chem
– volume: 11
  start-page: 779
  year: 2018
  publication-title: Materials
– volume: 124
  start-page: 184
  year: 2018
  publication-title: Mol. Genet. Metab.
– volume: 13
  start-page: 990
  year: 2019
  publication-title: Nanotoxicology
– volume: 28
  start-page: 1214
  year: 2021
  publication-title: Drug Delivery
– volume: 578
  year: 2020
  publication-title: Int. J. Pharm.
– volume: 10
  start-page: 2659
  year: 2018
  publication-title: Future Med. Chem.
– volume: 11
  start-page: 9687
  year: 2021
  publication-title: Theranostics
– volume: 8
  year: 2019
  publication-title: Adv. Healthcare Mater.
– volume: 30
  year: 2019
  publication-title: Nanotechnology
– volume: 329
  start-page: 1139
  year: 2021
  publication-title: J. Controlled Release
– year: 2023
  publication-title: Prog. Mater. Sci.
– volume: 476
  start-page: 2111
  year: 2021
  publication-title: Mol. Cell. Biochem.
– volume: 21
  start-page: 1535
  year: 2021
  publication-title: Chem. Rec.
– volume: 8
  start-page: 1335
  year: 2017
  publication-title: Front Immunol
– volume: 13
  start-page: 3690
  year: 2021
  publication-title: Cancers
– volume: 15
  start-page: 1571
  year: 2015
  publication-title: Macromol. Biosci.
– volume: 46
  start-page: 890
  year: 2018
  publication-title: Cell. Physiol. Biochem.
– year: 2022
  publication-title: Adv. Drug Delivery Rev.
– volume: 11
  start-page: 1923
  year: 2023
  publication-title: Biomater. Sci.
– volume: 4
  start-page: 645
  year: 2020
  publication-title: Emerg Top Life Sci.
– start-page: 179
  year: 2019
  publication-title: Frontiers in Materials
– volume: 33
  start-page: S85
  year: 2018
  publication-title: Indian J Nucl Med
– volume: 109
  start-page: 220
  year: 2020
  publication-title: Acta Biomater.
– volume: 6
  start-page: 126
  year: 2022
  publication-title: Nanotheranostics
– volume: 91
  year: 2019
  publication-title: Anal. Chem.
– volume: 22
  year: 2018
  publication-title: Riv. Eur. Sci. Med. Farmacol.
– volume: 14
  year: 2021
  publication-title: Front Mol Neurosci
– volume: 32
  start-page: 3133
  year: 2018
  publication-title: FASEB J.
– volume: 144
  start-page: 46
  year: 2019
  publication-title: Brain Res. Bull.
– volume: 20
  year: 2023
  publication-title: Mater Today Bio
– volume: 27
  start-page: 4247
  year: 2017
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 53
  start-page: 437
  year: 2015
  publication-title: Biomaterials
– volume: 6
  year: 2020
  publication-title: Sci. Adv.
– volume: 72
  start-page: 648
  year: 2012
  publication-title: Ann. Neurol.
– volume: 258
  start-page: 56
  year: 2017
  publication-title: J. Controlled Release
– volume: 170
  start-page: 312
  year: 2021
  publication-title: Adv. Drug Delivery Rev.
– volume: 104
  start-page: 158
  year: 2016
  publication-title: Biomaterials
– volume: 17
  start-page: 95
  year: 2022
  publication-title: Nat. Protoc.
– volume: 68
  start-page: 316
  year: 2020
  publication-title: Chem. Pharm. Bull.
– start-page: 183
  year: 2019
  end-page: 192
– volume: 329
  year: 2020
  publication-title: J Neurosci Methods
– volume: 21
  start-page: iv3
  year: 2019
  publication-title: Neuro Oncol
– volume: 349
  start-page: 269
  year: 2022
  publication-title: J. Controlled Release
– volume: 12
  start-page: 301
  year: 2022
  publication-title: Biotech
– volume: 10
  start-page: 3850
  year: 2019
  publication-title: Nat. Commun.
– volume: 18
  start-page: 143
  year: 2020
  publication-title: J. Nanobiotechnol.
– volume: 8
  start-page: 1435
  year: 2018
  publication-title: Theranostics
– volume: 33
  start-page: 1
  year: 2021
  publication-title: J. Cluster Sci.
– volume: 11
  start-page: 1841
  year: 2018
  publication-title: ACS Appl. Mater. Interfaces
– volume: 3
  start-page: 6546
  year: 2020
  publication-title: ACS Appl Bio Mater
– year: 2022
  publication-title: J Drug Deliv Sci Technol
– start-page: 4919
  year: 2020
  publication-title: Int. J. Nanomed.
– volume: 5
  start-page: 9558
  year: 2017
  publication-title: J. Mater. Chem. B
– volume: 112
  start-page: 53
  year: 2017
  publication-title: Carbon
– volume: 20
  start-page: 26
  year: 2020
  publication-title: Nat. Rev. Cancer
– volume: 289
  start-page: 14
  year: 2018
  publication-title: J. Controlled Release
– start-page: 262
  year: 2020
  publication-title: Semin. Cancer Biol.
– volume: 10
  start-page: 426
  year: 2022
  publication-title: Processes
– volume: 37
  start-page: 112
  year: 2020
  publication-title: Mater. Today
– volume: 23
  start-page: 885
  year: 2018
  publication-title: Cell Stress Chaperones
– volume: 16
  start-page: 106
  year: 2014
  publication-title: NeuroMol. Med.
– volume: 10
  start-page: 88
  year: 2018
  publication-title: Curr. Opin. Electrochem.
– volume: 10
  start-page: 640
  year: 2013
  publication-title: Mol. Pharmaceutics
– volume: 19
  start-page: 361
  year: 2020
  publication-title: Lancet Neurol.
– volume: 59
  start-page: 1909
  year: 2018
  publication-title: J. Chem. Inf. Model.
– volume: 48
  start-page: 1569
  year: 2019
  publication-title: Dalton Trans.
– volume: 13
  year: 2017
  publication-title: Small
– volume: 14
  start-page: 1317
  year: 2021
  publication-title: OncoTargets Ther.
– volume: 45
  start-page: 1733
  year: 2019
  publication-title: Ultrasound Med. Biol.
– volume: 250
  start-page: 1
  year: 2017
  publication-title: Sens. Actuators, B
– volume: 28
  start-page: 1497
  year: 2017
  publication-title: J Biomater Sci Polym Ed
– volume: 18
  start-page: 4985
  year: 2018
  publication-title: Nano Lett.
– volume: 156
  start-page: 155
  year: 2020
  publication-title: Eur. J. Pharm. Biopharm.
– volume: 15
  start-page: 2841
  year: 2020
  publication-title: Int. J. Nanomed.
– volume: 22
  start-page: 6606
  year: 2022
  publication-title: Nano Lett.
– volume: 166
  start-page: 13
  year: 2018
  publication-title: Biomaterials
– volume: 20
  start-page: 542
  year: 2022
  publication-title: J. Nanobiotechnol.
– volume: 21
  start-page: 1611
  year: 2020
  publication-title: Int. J. Mol. Sci.
– volume: 157
  start-page: 266
  year: 2018
  publication-title: Biochem. Pharmacol.
– volume: 17
  start-page: 1239
  year: 2020
  publication-title: Curr. Alzheimer Res.
– volume: 6
  start-page: 5106
  year: 2023
  publication-title: ACS Appl. Nano Mater.
– volume: 3
  year: 2021
  publication-title: Front Med Technol
– volume: 10
  start-page: 139
  year: 2018
  publication-title: Pharmaceutics
– volume: 13
  start-page: 83
  year: 2017
  publication-title: Nanomedicine
– volume: 7
  year: 2018
  publication-title: F1000Research
– volume: 11
  start-page: 607
  year: 2020
  publication-title: Cardiovasc Eng Technol
– volume: 23
  start-page: 6279
  year: 2017
  publication-title: Clin. Cancer Res.
– volume: 2
  start-page: 168
  year: 2018
  publication-title: Nanotheranostics
– volume: 211
  start-page: 48
  year: 2019
  publication-title: Biomaterials
– volume: 12
  start-page: 186
  year: 2020
  publication-title: Pharmaceutics
– volume: 33
  start-page: 660
  year: 2018
  publication-title: Movement Disord.
– volume: 16
  start-page: 13
  year: 2018
  publication-title: J. Nanobiotechnol.
– volume: 303
  start-page: 117
  year: 2019
  publication-title: J. Controlled Release
– volume: 60
  start-page: 3824
  year: 2023
  publication-title: Mol. Neurobiol.
– volume: 14
  start-page: 1833
  year: 2018
  publication-title: Nanomedicine
– volume: 47
  start-page: 2002
  year: 2022
  publication-title: Neurochem. Res.
– volume: 340
  start-page: 271
  year: 2021
  publication-title: J. Controlled Release
– volume: 37
  start-page: 635
  year: 2017
  publication-title: Curr Med Sci
– volume: 26
  start-page: 3319
  year: 2020
  publication-title: Clin. Cancer Res.
– volume: 124
  start-page: 33
  year: 2017
  publication-title: J Neural Transm
– volume: 8
  start-page: 364
  year: 2017
  publication-title: MedChemComm
– volume: 9
  start-page: 5864
  year: 2017
  publication-title: ACS Appl. Mater. Interfaces
– volume: 15
  start-page: 1812
  year: 2014
  publication-title: Int. J. Mol. Sci.
– volume: 9
  year: 2017
  publication-title: Nanoscale
– volume: 147
  start-page: 403
  year: 2022
  publication-title: Acta Biomater.
– volume: 27
  start-page: 36
  year: 2021
  publication-title: CNS Neurosci. Ther.
– volume: 5
  start-page: 213
  year: 2021
  publication-title: Nanotheranostics
– volume: 6
  start-page: 948
  year: 2016
  publication-title: Theranostics
– volume: 25
  start-page: 3814
  year: 2020
  publication-title: Molecules
– volume: 9
  start-page: 1834
  year: 2021
  publication-title: Biomedicines
– volume: 19
  start-page: 983
  year: 2019
  publication-title: Expert Rev. Neurother.
– volume: 11
  start-page: 981
  year: 2018
  publication-title: Arabian J. Chem.
– volume: 29
  year: 2019
  publication-title: Eur. J. Transl. Myol.
– volume: 109
  start-page: 1100
  year: 2019
  publication-title: Biomed. Pharmacother.
– volume: 189
  start-page: 123
  year: 2014
  publication-title: J. Controlled Release
– volume: 12
  year: 2018
  publication-title: ACS Nano
– volume: 15
  year: 2019
  publication-title: Small
– volume: 8
  start-page: 967
  year: 2017
  publication-title: Ther. Delivery
– volume: 28
  start-page: 182
  year: 2023
  publication-title: Mol Ther Oncolytics
– volume: 210
  start-page: 530
  year: 2022
  publication-title: Int. J. Biol. Macromol.
– volume: 9
  year: 2017
  publication-title: ACS Appl. Mater. Interfaces
– volume: 73
  start-page: 52
  year: 2018
  publication-title: Acta Biomater.
– volume: 84
  start-page: 211
  year: 2019
  publication-title: Bioorg. Chem.
– volume: 224
  start-page: 112
  year: 2016
  publication-title: J. Controlled Release
– volume: 13
  start-page: 97
  year: 2018
  publication-title: ACS Nano
– start-page: 3
  year: 2020
  end-page: 25
– year: 2023
  publication-title: Adv. Drug Delivery Rev.
– volume: 7
  start-page: 753
  year: 2010
  publication-title: Expert Opin. Drug Delivery
– volume: 6
  start-page: 309
  year: 2021
  publication-title: Signal Transduction Targeted Ther.
– start-page: 375
  year: 2018
  end-page: 396
– volume: 608
  start-page: 2964
  year: 2022
  publication-title: J. Colloid Interface Sci.
– volume: 23
  start-page: 1007
  year: 2018
  publication-title: Drug Discovery Today
– volume: 20
  start-page: 4177
  year: 2020
  publication-title: Nano Lett.
– volume: 44
  start-page: 15
  year: 2019
  publication-title: Curr. Opin. Pharmacol.
– volume: 18
  start-page: 2694
  year: 2021
  publication-title: Mol. Pharmaceutics
– volume: 225
  start-page: 217
  year: 2016
  publication-title: J. Controlled Release
– volume: 1788
  year: 2022
  publication-title: Brain Res.
– volume: 2
  start-page: 463
  year: 2019
  publication-title: Emergent Mater.
– volume: 561
  start-page: 161
  year: 2019
  publication-title: Int. J. Pharm.
– volume: 42
  start-page: 1709
  year: 2019
  publication-title: Oncol Rep
– volume: 35
  year: 2020
  publication-title: Nano Today
– volume: 166
  start-page: 45
  year: 2018
  publication-title: Colloids Surf., B
– volume: 16
  start-page: 675
  year: 2020
  publication-title: Stem Cell Rev Rep
– volume: 11
  start-page: 1987
  year: 2018
  publication-title: Nano Res.
– volume: 56
  start-page: 1566
  year: 2017
  publication-title: Angew. Chem., Int. Ed.
– volume: 295
  start-page: 237
  year: 2019
  publication-title: J. Controlled Release
– volume: 180
  start-page: 117
  year: 2018
  publication-title: Biomaterials
– volume: 26
  start-page: 700
  year: 2019
  publication-title: Drug Deliv.
– volume: 27
  start-page: 1372
  year: 2022
  publication-title: Molecules
– volume: 20
  start-page: 18
  year: 2018
  publication-title: AAPS J.
– volume: 46
  start-page: 4150
  year: 2017
  publication-title: Chem. Soc. Rev.
– year: 2023
  publication-title: Biochem. Pharmacol.
– volume: 12
  start-page: 1533
  year: 2017
  publication-title: Nanomedicine
– volume: 14
  year: 2018
  publication-title: Small
– volume: 364
  start-page: 10
  year: 2018
  publication-title: Coord. Chem. Rev.
– volume: 218
  year: 2019
  publication-title: Biomaterials
– volume: 13
  start-page: 1279
  year: 2022
  publication-title: Micromachines
– volume: 24
  start-page: 1782
  year: 2017
  publication-title: Drug Delivery
– volume: 1
  start-page: 671
  year: 2019
  publication-title: Nanoscale Adv
– volume: 35
  year: 2019
  publication-title: Langmuir
– volume: 44
  start-page: 381
  year: 2016
  publication-title: Artif. Cells, Nanomed., Biotechnol.
– volume: 13
  start-page: 892
  year: 2020
  publication-title: Energies
– volume: 86
  start-page: 343
  year: 2017
  publication-title: Biomed. Pharmacother.
– volume: 107
  start-page: 2902
  year: 2018
  publication-title: J. Pharm. Sci.
– volume: 2016
  year: 2016
  publication-title: Mediators Inflamm.
– year: 2023
  publication-title: Environ. Res.
– volume: 13
  start-page: 5591
  year: 2019
  publication-title: ACS Nano
– volume: 14
  start-page: 497
  year: 2019
  publication-title: Annu. Rev. Pathol.: Mech. Dis.
– volume: 57
  start-page: 192
  year: 2022
  publication-title: Mater. Today
– volume: 82
  start-page: 770
  year: 2017
  publication-title: ChemPlusChem
– volume: 19
  start-page: 1584
  year: 2013
  publication-title: Nat. Med.
– volume: 212
  start-page: 144
  year: 2018
  publication-title: Chem. Phys. Lipids
– volume: 30
  year: 2020
  publication-title: Adv. Funct. Mater.
– volume: 536
  start-page: 310
  year: 2018
  publication-title: Int. J. Pharm.
– volume: 12
  start-page: 6498
  year: 2020
  publication-title: Nanoscale
– year: 2017
  publication-title: JoVE
– year: 2022
– volume: 11
  start-page: 116
  year: 2022
  publication-title: Light Sci. Appl.
– volume: 96
  start-page: 114
  year: 2019
  publication-title: Mater. Sci. Eng., C
– volume: 26
  year: 2020
  publication-title: Med Sci Monit
– volume: 323
  year: 2020
  publication-title: Exp Neurol
– volume: 11
  year: 2019
  publication-title: Nanoscale
– volume: 260
  start-page: 61
  year: 2017
  publication-title: J. Controlled Release
– volume: 25
  start-page: 3731
  year: 2020
  publication-title: Molecules
– volume: 19
  start-page: 29
  year: 2021
  publication-title: J. Nanobiotechnol.
– volume: 38
  start-page: 1667
  year: 2018
  publication-title: J. Cereb. Blood Flow Metab.
– volume: 7
  start-page: 6271
  year: 2019
  publication-title: J. Mater. Chem. B
– volume: 15
  start-page: 2499
  year: 2023
  publication-title: ACS Appl. Mater. Interfaces
– volume: 256
  start-page: 25
  year: 2016
  publication-title: Chem.‐Biol. Interact.
– volume: 6
  start-page: 529
  year: 2021
  publication-title: Bioact Mater
– volume: 304
  start-page: 29
  year: 2019
  publication-title: J. Controlled Release
– volume: 61
  start-page: 392
  year: 2018
  publication-title: Sci China Life Sci
– volume: 6
  start-page: 2982
  year: 2014
  publication-title: Anal. Methods
– volume: 7
  year: 2015
  publication-title: Cold Spring Harbor Perspect. Biol.
– volume: 8
  start-page: 9925
  year: 2014
  publication-title: ACS Nano
– volume: 9
  start-page: 1752
  year: 2019
  publication-title: Theranostics
– volume: 10
  start-page: 1703
  year: 2015
  publication-title: Int. J. Nanomed.
– volume: 261
  start-page: 392
  year: 2018
  publication-title: Sens. Actuators, B
– volume: 14
  start-page: 68
  year: 2021
  publication-title: Front Mol Neurosci
– volume: 160
  start-page: 159
  year: 2021
  publication-title: Radiother Oncol
– volume: 13
  start-page: 1311
  year: 2018
  publication-title: ChemMedChem
– volume: 26
  start-page: 459
  year: 2019
  publication-title: Drug Delivery
– volume: 48
  start-page: D127
  year: 2020
  publication-title: Nucleic Acids Res.
– volume: 12
  year: 2020
  publication-title: Nanoscale
– volume: 17
  year: 2021
  publication-title: Small
– volume: 12
  start-page: 2117
  year: 2017
  publication-title: Int. J. Nanomed.
– volume: 2019
  year: 2019
  publication-title: Contrast Media Mol. Imaging
– volume: 63
  start-page: 415
  year: 2019
  publication-title: Stud. Nat. Prod. Chem.
– volume: 31
  year: 2019
  publication-title: Adv. Mater.
– volume: 118
  start-page: 160
  year: 2010
  publication-title: Toxicol. Sci.
– volume: 82
  start-page: 143
  year: 2018
  publication-title: Acta Biomater.
– volume: 11
  year: 2019
  publication-title: ACS Appl. Mater. Interfaces
– volume: 11
  start-page: 481
  year: 2019
  publication-title: Pharmaceutics
– volume: 117
  year: 2020
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 17
  start-page: 33
  year: 2017
  publication-title: Curr. Neurol. Neurosci. Rep.
– start-page: 3591
  year: 2019
– volume: 9
  start-page: 8278
  year: 2019
  publication-title: Sci. Rep.
– volume: 114
  year: 2017
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 32
  year: 2020
  publication-title: Adv. Mater.
– volume: 19
  start-page: 7836
  year: 2019
  publication-title: Nano Lett.
– volume: 8
  start-page: 131
  year: 2022
  publication-title: Magnetochemistry
– volume: 176
  year: 2021
  publication-title: Adv. Drug Delivery Rev.
– volume: 11
  start-page: 6297
  year: 2019
  publication-title: Nanoscale
– volume: 111
  start-page: 666
  year: 2019
  publication-title: Biomed. Pharmacother.
– volume: 38
  start-page: 1021
  year: 2018
  publication-title: Cell. Mol. Neurobiol.
– volume: 12
  start-page: 1321
  year: 2018
  publication-title: ACS Nano
– volume: 13
  start-page: 5
  year: 2020
  publication-title: Pharmaceutics
– volume: 56
  year: 2020
  publication-title: Chem. Commun.
– start-page: 1681
  year: 2021
  publication-title: Int. J. Nanomed.
– year: 2019
  publication-title: bioRxiv
– volume: 33
  start-page: 785.8
  year: 2019
  publication-title: FASEB J.
– volume: 3
  start-page: 8059
  year: 2018
  publication-title: ACS Omega
– volume: 5
  start-page: 1677
  year: 2019
  publication-title: ACS Biomater. Sci. Eng.
– volume: 245
  year: 2020
  publication-title: Biomaterials
– volume: 16
  start-page: 258
  year: 2019
  publication-title: Nanomedicine
– volume: 13
  start-page: 895
  year: 2016
  publication-title: Neurotherapeutics
– volume: 14
  year: 2023
  publication-title: Front Neurol
– volume: 348
  start-page: 706
  year: 2022
  publication-title: J. Controlled Release
– volume: 38
  start-page: 727
  year: 2018
  publication-title: J. Cereb. Blood Flow Metab.
– volume: 12
  start-page: 1019
  year: 2019
  publication-title: Front. Neurosci.
– volume: 15
  start-page: 1931
  year: 2023
  publication-title: Aging
– volume: 12
  start-page: 1231
  year: 2017
  publication-title: Nanomedicine
– year: 2018
– volume: 24
  year: 2020
  publication-title: Nanomedicine
– volume: 316
  start-page: 12
  year: 2019
  publication-title: Exp Neurol
– volume: 34
  year: 2022
  publication-title: Adv. Mater.
– volume: 12
  start-page: 612
  year: 2018
  publication-title: Front. Neurosci.
– volume: 36
  year: 2020
  publication-title: Langmuir
– volume: 11
  start-page: 2306
  year: 2021
  publication-title: Acta Pharm. Sin. B
– volume: 8
  start-page: 178
  year: 2018
  publication-title: Nanomaterials
– volume: 9
  start-page: 2415
  year: 2018
  publication-title: Nat. Commun.
– volume: 18
  start-page: 714
  year: 2020
  publication-title: Mol. Pharmaceutics
– volume: 11
  start-page: 65
  year: 2019
  publication-title: Pharmaceutics
– volume: 6
  year: 2022
  publication-title: Small Methods.
– volume: 10
  start-page: 749
  year: 2018
  publication-title: Daru
– volume: 12
  start-page: 1775
  year: 2016
  publication-title: Nanomedicine
– volume: 47
  start-page: 8572
  year: 2018
  publication-title: Chem. Soc. Rev.
– volume: 38
  start-page: 133
  year: 2018
  publication-title: Cell. Mol. Neurobiol.
– volume: 25
  start-page: 3793
  year: 2019
  publication-title: Clin. Cancer Res.
– volume: 8
  start-page: 1231
  year: 2014
  publication-title: ACS Nano
– volume: 292
  start-page: 163
  year: 2018
  publication-title: J. Controlled Release
– volume: 8
  year: 2021
  publication-title: Adv. Sci.
– volume: 17
  year: 2023
  publication-title: ACS Nano
– volume: 3
  start-page: 311
  year: 2019
  publication-title: Nanotheranostics
– volume: 8
  start-page: 5538
  year: 2020
  publication-title: Biomater. Sci.
– volume: 12
  start-page: 1
  year: 2017
  publication-title: Res. Pharm. Sci.
– volume: 433
  year: 2022
  publication-title: Chem. Eng. J.
– volume: 26
  start-page: 868
  year: 2017
  publication-title: Adv Clin Exp Med
– volume: 101
  start-page: 1337
  year: 2012
  publication-title: J. Pharm. Sci.
– volume: 12
  start-page: 72
  year: 2020
  publication-title: Pharmaceutics
– year: 2023
  publication-title: Adv. Funct. Mater.
– volume: 13
  start-page: 386
  year: 2018
  publication-title: ACS Nano
– volume: 14
  start-page: 6191
  year: 2020
  publication-title: ACS Nano
– volume: 22
  start-page: 1068
  year: 2021
  publication-title: Int. J. Mol. Sci.
– volume: 12
  start-page: 1006
  year: 2017
  publication-title: Nat. Nanotechnol.
– volume: 17
  start-page: 23
  year: 2020
  publication-title: Expert Opin. Drug Delivery
– volume: 21
  start-page: 275
  year: 2018
  publication-title: Photodiagn. Photodyn. Ther.
– volume: 4
  start-page: 46
  year: 2018
  publication-title: ChemNanoMat
– volume: 211
  year: 2023
  publication-title: Mechan. Ageing Dev.
– volume: 6
  start-page: 314
  year: 2018
  publication-title: Biomater. Sci.
– volume: 15
  year: 2021
  publication-title: ACS Nano
– volume: 10
  year: 2018
  publication-title: Nanoscale
– volume: 13
  year: 2019
  publication-title: ACS Nano
– start-page: 1
  year: 2021
  end-page: 27
– volume: 13
  start-page: 500
  year: 2021
  publication-title: Pharmaceutics
– volume: 19
  start-page: 60
  year: 2021
  publication-title: J. Nanobiotechnol.
– year: 2012
– volume: 7
  start-page: 3
  year: 2017
  publication-title: Adv. Pharm. Bull.
– volume: 143
  year: 2021
  publication-title: Biomed. Pharmacother.
– volume: 10
  year: 2020
  publication-title: Front Oncol
– volume: 16
  start-page: 4105
  year: 2021
  publication-title: Int. J. Nanomed.
– volume: 30
  year: 2018
  publication-title: Adv. Mater.
– volume: 264
  start-page: 102
  year: 2017
  publication-title: J. Controlled Release
– volume: 21
  start-page: 22
  year: 2019
  publication-title: Int. J. Mol. Sci.
– volume: 48
  start-page: 18
  year: 2017
  publication-title: J. Nano Res.
– start-page: 329
  year: 2019
  end-page: 342
– volume: 7
  year: 2021
  publication-title: Sci. Adv.
– volume: 11
  year: 2022
  publication-title: Front Oncol
– volume: 15
  start-page: 236
  year: 2023
  publication-title: Pharmaceutics
– volume: 48
  start-page: 2967
  year: 2019
  publication-title: Chem. Soc. Rev.
– volume: 27
  start-page: 103
  year: 2019
  publication-title: J. Drug Targeting
– volume: 104
  start-page: 2727
  year: 2015
  publication-title: J. Pharm. Sci.
– volume: 16
  start-page: 583
  year: 2019
  publication-title: Expert Opin. Drug Delivery
– volume: 67
  start-page: 779
  year: 2019
  publication-title: J. Alzheimers Dis.
– volume: 7
  year: 2015
  publication-title: Nanoscale
– year: 2017
– year: 2016
  publication-title: JoVE
– volume: 133
  start-page: 1380
  year: 2020
  publication-title: Am. J. Med.
– volume: 10
  year: 2020
  publication-title: Sci. Rep.
– year: 2016
  ident: e_1_2_17_328_1
  publication-title: JoVE
– ident: e_1_2_17_95_1
  doi: 10.7150/ntno.38954
– ident: e_1_2_17_236_1
  doi: 10.1016/j.apsb.2019.01.011
– ident: e_1_2_17_112_1
  doi: 10.1038/s41598-020-75253-9
– ident: e_1_2_17_37_1
  doi: 10.1016/j.biomaterials.2018.07.014
– ident: e_1_2_17_107_1
  doi: 10.1016/j.jconrel.2019.01.005
– ident: e_1_2_17_108_1
  doi: 10.1016/j.nano.2017.02.013
– ident: e_1_2_17_274_1
  doi: 10.1126/sciadv.aay1344
– ident: e_1_2_17_259_1
  doi: 10.1186/s13046-019-1180-5
– ident: e_1_2_17_20_1
  doi: 10.1158/1078-0432.CCR-18-3643
– ident: e_1_2_17_308_1
  doi: 10.1007/s12274-017-1815-9
– ident: e_1_2_17_218_1
  doi: 10.1208/s12248-017-0176-3
– ident: e_1_2_17_301_1
  doi: 10.1042/ETLS20190141
– ident: e_1_2_17_84_1
  doi: 10.1177/0271678X16662042
– ident: e_1_2_17_286_1
  doi: 10.3390/ma11050779
– ident: e_1_2_17_99_1
  doi: 10.1533/9780857096258
– ident: e_1_2_17_217_1
  doi: 10.1039/C8NR03828G
– ident: e_1_2_17_18_1
  doi: 10.1039/D0NR04035E
– ident: e_1_2_17_264_1
  doi: 10.1016/j.omto.2022.12.002
– ident: e_1_2_17_41_1
  doi: 10.1039/C7TB01314K
– ident: e_1_2_17_58_1
  doi: 10.1039/C9NR02866H
– ident: e_1_2_17_239_1
  doi: 10.1002/smtd.202200289
– ident: e_1_2_17_65_1
  doi: 10.1096/fasebj.2019.33.1_supplement.785.8
– ident: e_1_2_17_198_1
  doi: 10.1021/acs.langmuir.9b01617
– ident: e_1_2_17_227_1
  doi: 10.1021/acsami.1c00157
– ident: e_1_2_17_332_1
  doi: 10.1021/acsami.9b12319
– ident: e_1_2_17_209_1
  doi: 10.1021/acsnano.8b03785
– ident: e_1_2_17_340_1
  doi: 10.1016/j.amjmed.2020.05.049
– ident: e_1_2_17_142_1
  doi: 10.1016/j.msec.2018.10.094
– ident: e_1_2_17_213_1
  doi: 10.1039/C8CS00162F
– ident: e_1_2_17_219_1
  doi: 10.1038/s41467-018-04813-5
– ident: e_1_2_17_249_1
  doi: 10.1016/j.expneurol.2019.113094
– ident: e_1_2_17_346_1
  doi: 10.1155/2016/2847232
– ident: e_1_2_17_86_1
  doi: 10.1155/2019/6341545
– ident: e_1_2_17_67_1
  doi: 10.1016/j.jconrel.2018.10.034
– ident: e_1_2_17_119_1
  doi: 10.3390/pharmaceutics15010236
– ident: e_1_2_17_341_1
  doi: 10.1016/j.ijpharm.2017.12.010
– ident: e_1_2_17_173_1
  doi: 10.1016/j.carbon.2016.10.096
– ident: e_1_2_17_52_1
  doi: 10.1021/acsomega.8b00764
– ident: e_1_2_17_334_1
  doi: 10.1016/j.nano.2019.102119
– ident: e_1_2_17_3_1
  doi: 10.1177/0271678X17740031
– ident: e_1_2_17_211_1
  doi: 10.1016/j.ultrasmedbio.2019.02.024
– ident: e_1_2_17_222_1
  doi: 10.1016/j.ccr.2018.03.007
– ident: e_1_2_17_165_1
  doi: 10.1002/adfm.202002560
– ident: e_1_2_17_96_1
  doi: 10.3390/cancers13153690
– ident: e_1_2_17_275_1
  doi: 10.1021/acsnano.8b06556
– ident: e_1_2_17_277_1
  doi: 10.1021/acsami.6b15831
– ident: e_1_2_17_31_1
  doi: 10.1007/s11010-021-04053-0
– ident: e_1_2_17_251_1
  doi: 10.1007/s12035-023-03318-7
– ident: e_1_2_17_196_1
  doi: 10.3390/ijms21051611
– ident: e_1_2_17_151_1
  doi: 10.1002/tcr.202000104
– ident: e_1_2_17_1_1
  doi: 10.3390/biomedicines9121834
– ident: e_1_2_17_162_1
  doi: 10.1039/C9TB01042D
– ident: e_1_2_17_204_1
  doi: 10.1016/j.jconrel.2017.05.013
– ident: e_1_2_17_289_1
  doi: 10.1016/j.jconrel.2016.01.015
– ident: e_1_2_17_34_1
  doi: 10.1002/jps.24329
– ident: e_1_2_17_155_1
  doi: 10.1016/j.coelec.2018.03.017
– ident: e_1_2_17_30_1
– ident: e_1_2_17_163_1
  doi: 10.1021/acsami.9b10787
– ident: e_1_2_17_201_1
  doi: 10.1016/j.snb.2018.01.149
– ident: e_1_2_17_248_1
  doi: 10.1093/nar/gkz757
– ident: e_1_2_17_262_1
  doi: 10.3390/pharmaceutics15071833
– ident: e_1_2_17_5_1
  doi: 10.1016/j.envres.2023.116563
– ident: e_1_2_17_178_1
  doi: 10.1016/j.biomaterials.2015.02.083
– ident: e_1_2_17_153_1
  doi: 10.1016/j.biopha.2018.10.167
– ident: e_1_2_17_240_1
  doi: 10.1186/s12951-022-01746-6
– ident: e_1_2_17_320_1
  doi: 10.1146/annurev-pathmechdis-012418-013109
– ident: e_1_2_17_326_1
  doi: 10.1039/C3AY42207K
– ident: e_1_2_17_292_1
  doi: 10.1088/1361-6528/ab0f46
– ident: e_1_2_17_244_1
  doi: 10.1016/j.bioactmat.2020.08.017
– ident: e_1_2_17_90_1
  doi: 10.1021/acs.nanolett.8b01818
– ident: e_1_2_17_100_1
  doi: 10.1016/j.jconrel.2014.06.031
– ident: e_1_2_17_156_1
  doi: 10.1016/j.arabjc.2018.03.019
– ident: e_1_2_17_167_1
  doi: 10.1039/C5NR05649G
– ident: e_1_2_17_282_1
  doi: 10.1002/mabi.201500091
– ident: e_1_2_17_161_1
  doi: 10.1002/cnma.201700264
– ident: e_1_2_17_36_1
  doi: 10.1177/0271678X18788769
– ident: e_1_2_17_307_1
  doi: 10.1021/acsnano.7b07625
– ident: e_1_2_17_66_1
  doi: 10.3390/ijms22031068
– ident: e_1_2_17_128_1
  doi: 10.1016/B978-0-12-817901-7.00013-7
– ident: e_1_2_17_27_1
  doi: 10.1016/j.jconrel.2019.05.005
– ident: e_1_2_17_59_1
  doi: 10.1093/neuonc/noz167.011
– ident: e_1_2_17_323_1
  doi: 10.1021/acs.jcim.8b00725
– ident: e_1_2_17_70_1
  doi: 10.2147/IJN.S314895
– ident: e_1_2_17_238_1
  doi: 10.1016/j.biomaterials.2020.119987
– ident: e_1_2_17_164_1
  doi: 10.1021/acsami.9b07980
– ident: e_1_2_17_62_1
  doi: 10.1039/C9NR03931G
– volume: 10
  start-page: 749
  year: 2018
  ident: e_1_2_17_121_1
  publication-title: Daru
– ident: e_1_2_17_145_1
  doi: 10.1016/j.bioorg.2018.11.034
– ident: e_1_2_17_94_1
  doi: 10.1038/s41377-022-00794-9
– ident: e_1_2_17_310_1
  doi: 10.1016/j.biomaterials.2016.06.056
– ident: e_1_2_17_273_1
  doi: 10.1002/adma.201800766
– ident: e_1_2_17_257_1
  doi: 10.1096/fj.201701121R
– ident: e_1_2_17_143_1
  doi: 10.3390/biomedicines8010013
– ident: e_1_2_17_6_1
  doi: 10.1016/j.jconrel.2022.06.050
– ident: e_1_2_17_212_1
  doi: 10.1016/j.pmatsci.2023.101190
– ident: e_1_2_17_91_1
  doi: 10.3390/cancers13030503
– ident: e_1_2_17_60_1
  doi: 10.1016/B978-0-12-812218-1.00014-2
– ident: e_1_2_17_333_1
  doi: 10.1007/s12017-013-8261-y
– ident: e_1_2_17_85_1
  doi: 10.1002/cmdc.201800262
– ident: e_1_2_17_42_1
  doi: 10.1093/toxsci/kfq244
– ident: e_1_2_17_202_1
  doi: 10.1016/j.ijpharm.2019.02.022
– ident: e_1_2_17_256_1
  doi: 10.18632/aging.204573
– ident: e_1_2_17_40_1
  doi: 10.3390/ijms15021812
– ident: e_1_2_17_177_1
  doi: 10.1007/s11596-017-1783-z
– ident: e_1_2_17_126_1
  doi: 10.3390/molecules25163731
– ident: e_1_2_17_127_1
  doi: 10.1016/B978-0-08-102985-5.00001-2
– ident: e_1_2_17_314_1
  doi: 10.1002/mds.27360
– ident: e_1_2_17_134_1
  doi: 10.3390/pharmaceutics13040500
– ident: e_1_2_17_148_1
  doi: 10.1016/j.jconrel.2017.04.033
– ident: e_1_2_17_166_1
  doi: 10.3390/molecules25173814
– ident: e_1_2_17_319_1
  doi: 10.1038/s41598-021-94175-8
– ident: e_1_2_17_189_1
– ident: e_1_2_17_207_1
  doi: 10.2147/IJN.S239608
– ident: e_1_2_17_297_1
  doi: 10.1002/adhm.201900543
– ident: e_1_2_17_74_1
  doi: 10.1002/smll.202006484
– ident: e_1_2_17_75_1
  doi: 10.1002/adfm.202003054
– ident: e_1_2_17_230_1
  doi: 10.1080/10717544.2021.1937384
– ident: e_1_2_17_22_1
  doi: 10.3389/fnmol.2021.618360
– ident: e_1_2_17_276_1
  doi: 10.7150/ntno.54491
– ident: e_1_2_17_255_1
  doi: 10.1159/000488821
– ident: e_1_2_17_241_1
  doi: 10.1016/j.biomaterials.2019.04.026
– ident: e_1_2_17_73_1
  doi: 10.1002/jbm.a.36145
– ident: e_1_2_17_169_1
  doi: 10.3390/pharmaceutics12090890
– ident: e_1_2_17_321_1
  doi: 10.1016/S1474-4422(19)30403-X
– ident: e_1_2_17_61_1
  doi: 10.1016/j.jconrel.2017.05.019
– ident: e_1_2_17_83_1
  doi: 10.1158/1538-7445.AM2018-CT013
– ident: e_1_2_17_168_1
  doi: 10.1016/j.jcis.2021.11.019
– ident: e_1_2_17_205_1
  doi: 10.1021/acs.nanolett.0c00495
– ident: e_1_2_17_223_1
  doi: 10.1039/D0CC05878E
– ident: e_1_2_17_8_1
  doi: 10.1039/C6MD00481D
– ident: e_1_2_17_93_1
  doi: 10.1016/j.ijbiomac.2022.04.207
– ident: e_1_2_17_199_1
  doi: 10.1021/acsnano.1c01669
– ident: e_1_2_17_12_1
  doi: 10.1038/nm.3407
– ident: e_1_2_17_44_1
  doi: 10.1080/17435390.2019.1621398
– ident: e_1_2_17_81_1
  doi: 10.1186/s12951-020-00705-3
– ident: e_1_2_17_281_1
  doi: 10.1021/acsnano.0c02249
– ident: e_1_2_17_150_1
  doi: 10.1016/j.addr.2023.115115
– ident: e_1_2_17_15_1
  doi: 10.1016/j.brainres.2022.147937
– ident: e_1_2_17_215_1
  doi: 10.1016/j.jconrel.2020.10.043
– ident: e_1_2_17_235_1
  doi: 10.3389/fonc.2020.563938
– ident: e_1_2_17_250_1
  doi: 10.1016/j.expneurol.2019.03.017
– ident: e_1_2_17_55_1
  doi: 10.4155/fmc-2018-0208
– ident: e_1_2_17_345_1
  doi: 10.2217/nnm-2016-0410
– ident: e_1_2_17_69_1
  doi: 10.1021/acsnano.8b05265
– ident: e_1_2_17_242_1
  doi: 10.1021/acs.nanolett.2c01863
– ident: e_1_2_17_35_1
  doi: 10.2147/DDDT.S218708
– ident: e_1_2_17_24_1
  doi: 10.1016/j.jneumeth.2019.108478
– ident: e_1_2_17_344_1
  doi: 10.3389/fneur.2023.1149963
– ident: e_1_2_17_210_1
  doi: 10.1021/acsnano.9b01808
– ident: e_1_2_17_232_1
  doi: 10.1016/j.jconrel.2017.08.027
– ident: e_1_2_17_111_1
  doi: 10.1080/1061186X.2018.1497037
– ident: e_1_2_17_237_1
  doi: 10.1016/j.mtbio.2023.100674
– ident: e_1_2_17_278_1
  doi: 10.1158/1078-0432.CCR-16-2598
– ident: e_1_2_17_225_1
  doi: 10.1021/nn406197c
– ident: e_1_2_17_336_1
  doi: 10.1021/acsami.7b06510
– ident: e_1_2_17_13_1
  doi: 10.1111/cns.13569
– ident: e_1_2_17_298_1
  doi: 10.1002/adma.202106194
– ident: e_1_2_17_97_1
  doi: 10.1039/D2BM01594C
– ident: e_1_2_17_135_1
  doi: 10.1186/s12951-018-0340-7
– ident: e_1_2_17_71_1
  doi: 10.3390/ijms21010022
– ident: e_1_2_17_224_1
– ident: e_1_2_17_129_1
  doi: 10.4155/tde-2017-0075
– ident: e_1_2_17_331_1
  doi: 10.1080/14737175.2019.1631161
– ident: e_1_2_17_184_1
  doi: 10.3109/21691401.2014.953633
– ident: e_1_2_17_203_1
  doi: 10.1016/j.colsurfb.2018.02.061
– ident: e_1_2_17_247_1
  doi: 10.17219/acem/62915
– ident: e_1_2_17_234_1
  doi: 10.1016/j.addr.2020.09.001
– ident: e_1_2_17_261_1
  doi: 10.1016/j.mad.2023.111800
– ident: e_1_2_17_270_1
  doi: 10.7150/thno.30977
– ident: e_1_2_17_265_1
  doi: 10.3389/fmedt.2021.678593
– ident: e_1_2_17_114_1
  doi: 10.3390/en13040892
– ident: e_1_2_17_299_1
  doi: 10.12688/f1000research.14506.1
– ident: e_1_2_17_124_1
  doi: 10.1016/j.nano.2016.04.008
– ident: e_1_2_17_137_1
  doi: 10.1016/j.ejpb.2020.09.003
– ident: e_1_2_17_343_1
  doi: 10.1016/j.biopha.2016.12.010
– ident: e_1_2_17_146_1
  doi: 10.1016/j.xphs.2018.07.020
– ident: e_1_2_17_7_1
  doi: 10.1016/j.jconrel.2022.06.026
– ident: e_1_2_17_33_1
  doi: 10.1002/jps.23022
– ident: e_1_2_17_138_1
  doi: 10.3390/pharmaceutics12010072
– ident: e_1_2_17_120_1
  doi: 10.1007/s00775-020-01834-8
– ident: e_1_2_17_174_1
  doi: 10.7150/thno.15217
– ident: e_1_2_17_64_1
  doi: 10.1016/j.nano.2016.08.029
– ident: e_1_2_17_245_1
  doi: 10.1016/j.cej.2021.133848
– ident: e_1_2_17_268_1
  doi: 10.1002/adma.201902504
– ident: e_1_2_17_208_1
  doi: 10.3390/nano8030178
– ident: e_1_2_17_188_1
  doi: 10.1016/j.ijpharm.2020.119045
– ident: e_1_2_17_335_1
  doi: 10.1021/mp3003946
– ident: e_1_2_17_348_1
  doi: 10.3389/fimmu.2017.01335
– ident: e_1_2_17_216_1
  doi: 10.2147/IJN.S123422
– ident: e_1_2_17_104_1
  doi: 10.3390/pr10020426
– ident: e_1_2_17_231_1
  doi: 10.1021/acsnano.9b00661
– ident: e_1_2_17_176_1
  doi: 10.1002/adma.201802368
– ident: e_1_2_17_243_1
  doi: 10.1002/adfm.202213292
– ident: e_1_2_17_113_1
  doi: 10.1016/j.jddst.2022.103899
– ident: e_1_2_17_318_1
  doi: 10.1016/j.actbio.2020.03.021
– ident: e_1_2_17_325_1
  doi: 10.4028/www.scientific.net/JNanoR.48.18
– ident: e_1_2_17_47_1
  doi: 10.1016/j.drudis.2017.11.010
– volume: 42
  start-page: 1709
  year: 2019
  ident: e_1_2_17_283_1
  publication-title: Oncol Rep
– ident: e_1_2_17_272_1
  doi: 10.1002/adma.201802591
– ident: e_1_2_17_337_1
  doi: 10.1016/j.cbi.2016.05.020
– ident: e_1_2_17_21_1
  doi: 10.1080/10717544.2019.1571123
– ident: e_1_2_17_342_1
  doi: 10.7150/ntno.63158
– ident: e_1_2_17_25_1
  doi: 10.3390/pharmaceutics11090481
– ident: e_1_2_17_115_1
  doi: 10.1007/s12015-020-09966-9
– ident: e_1_2_17_79_1
  doi: 10.1007/978-1-4939-8946-1_19
– ident: e_1_2_17_28_1
  doi: 10.1016/j.biopha.2018.12.133
– ident: e_1_2_17_214_1
  doi: 10.1002/advs.202102001
– ident: e_1_2_17_11_1
  doi: 10.1002/ana.23648
– ident: e_1_2_17_50_1
  doi: 10.1002/smll.201701921
– start-page: 183
  volume-title: Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XVI
  year: 2019
  ident: e_1_2_17_109_1
– ident: e_1_2_17_130_1
  doi: 10.1021/acsabm.0c01039
– ident: e_1_2_17_29_1
  doi: 10.1016/j.biopha.2021.112117
– ident: e_1_2_17_302_1
  doi: 10.2174/1567205018666210218160812
– ident: e_1_2_17_179_1
  doi: 10.1016/j.jconrel.2016.01.031
– ident: e_1_2_17_56_1
  doi: 10.1016/j.nano.2019.01.014
– ident: e_1_2_17_221_1
  doi: 10.1021/acsami.2c12370
– ident: e_1_2_17_89_1
  doi: 10.1002/adma.201903759
– ident: e_1_2_17_19_1
  doi: 10.1016/j.brainresbull.2018.11.006
– ident: e_1_2_17_140_1
  doi: 10.1007/s00702-016-1527-4
– ident: e_1_2_17_303_1
  doi: 10.1039/D0BM00756K
– ident: e_1_2_17_23_1
  doi: 10.1016/j.ymgme.2018.05.003
– ident: e_1_2_17_72_1
  doi: 10.1080/17425247.2019.1614911
– ident: e_1_2_17_154_1
  doi: 10.1002/cplu.201700078
– ident: e_1_2_17_160_1
  doi: 10.3390/ijms21072586
– ident: e_1_2_17_269_1
  doi: 10.1126/sciadv.abd0772
– ident: e_1_2_17_180_1
  doi: 10.1073/pnas.1616070114
– ident: e_1_2_17_267_1
  doi: 10.3390/pharmaceutics12020186
– ident: e_1_2_17_200_1
  doi: 10.1016/j.chemphyslip.2018.01.007
– ident: e_1_2_17_329_1
  doi: 10.1371/journal.pone.0219995
– ident: e_1_2_17_123_1
  doi: 10.1039/C7BM01012E
– ident: e_1_2_17_87_1
  doi: 10.1039/C9NR09713A
– ident: e_1_2_17_290_1
  doi: 10.1007/s12192-018-0896-z
– ident: e_1_2_17_181_1
  doi: 10.2147/IJN.S68429
– ident: e_1_2_17_183_1
  doi: 10.3390/molecules27041372
– ident: e_1_2_17_125_1
  doi: 10.1021/acsbiomaterials.8b01420
– start-page: 1
  volume-title: Biodegradable Polymeric Nanoparticles for Brain‐Targeted Drug Delivery. Nanomedicines for Brain Drug Delivery
  year: 2021
  ident: e_1_2_17_133_1
– ident: e_1_2_17_46_1
  doi: 10.1039/C8CS00805A
– ident: e_1_2_17_171_1
  doi: 10.1186/s12951-021-00798-4
– ident: e_1_2_17_26_1
  doi: 10.3389/fnmol.2021.618360
– ident: e_1_2_17_116_1
  doi: 10.3389/fmats.2019.00179
– ident: e_1_2_17_141_1
  doi: 10.1007/s42247-019-00033-9
– ident: e_1_2_17_322_1
  doi: 10.1016/j.coph.2018.11.006
– ident: e_1_2_17_110_1
  doi: 10.1038/s41598-019-44569-6
– ident: e_1_2_17_193_1
  doi: 10.3390/pharmaceutics10030139
– ident: e_1_2_17_206_1
  doi: 10.1016/j.biomaterials.2018.03.004
– ident: e_1_2_17_309_1
  doi: 10.1007/s11427-017-9292-7
– ident: e_1_2_17_315_1
  doi: 10.3389/fnins.2018.00612
– ident: e_1_2_17_226_1
  doi: 10.7150/thno.22482
– ident: e_1_2_17_228_1
  doi: 10.1021/acsnano.3c03724
– ident: e_1_2_17_49_1
  doi: 10.1080/17425247.2020.1698544
– ident: e_1_2_17_53_1
  doi: 10.1016/j.mattod.2020.02.001
– ident: e_1_2_17_88_1
  doi: 10.1016/j.addr.2022.114539
– ident: e_1_2_17_4_1
  doi: 10.1016/j.mattod.2022.05.024
– ident: e_1_2_17_39_1
  doi: 10.2217/nnm-2017-0022
– volume: 22
  year: 2018
  ident: e_1_2_17_253_1
  publication-title: Riv. Eur. Sci. Med. Farmacol.
– ident: e_1_2_17_284_1
  doi: 10.1021/acs.bioconjchem.1c00321
– ident: e_1_2_17_159_1
  doi: 10.1002/smll.201900669
– ident: e_1_2_17_17_1
  doi: 10.1248/cpb.c19-00854
– ident: e_1_2_17_54_1
  doi: 10.1038/s41467-019-11719-3
– ident: e_1_2_17_252_1
  doi: 10.1007/s11064-022-03585-1
– ident: e_1_2_17_48_1
  doi: 10.1073/pnas.2002016117
– ident: e_1_2_17_103_1
  doi: 10.3389/fonc.2021.819329
– ident: e_1_2_17_313_1
  doi: 10.1016/j.bmcl.2017.07.075
– ident: e_1_2_17_295_1
  doi: 10.1021/acs.molpharmaceut.1c00224
– ident: e_1_2_17_170_1
  doi: 10.1039/C7NR04445C
– ident: e_1_2_17_280_1
  doi: 10.1021/acsami.0c03873
– ident: e_1_2_17_229_1
  doi: 10.1016/j.actbio.2022.05.029
– ident: e_1_2_17_118_1
  doi: 10.3390/mi13081279
– ident: e_1_2_17_182_1
  doi: 10.1039/C9NR08194A
– ident: e_1_2_17_288_1
  doi: 10.1158/1078-0432.CCR-19-3538
– ident: e_1_2_17_102_1
  doi: 10.1517/17425241003777010
– ident: e_1_2_17_260_1
  doi: 10.1016/j.biomaterials.2019.119342
– ident: e_1_2_17_285_1
  doi: 10.1016/j.actbio.2018.10.012
– ident: e_1_2_17_172_1
  doi: 10.7150/ntno.23125
– ident: e_1_2_17_38_1
  doi: 10.1038/s41596-021-00635-w
– year: 2017
  ident: e_1_2_17_144_1
  publication-title: JoVE
– ident: e_1_2_17_106_1
  doi: 10.1038/s41598-020-75125-2
– ident: e_1_2_17_279_1
  doi: 10.4081/ejtm.2019.8209
– year: 2019
  ident: e_1_2_17_197_1
  publication-title: bioRxiv
– ident: e_1_2_17_294_1
  doi: 10.1016/j.jconrel.2019.04.031
– ident: e_1_2_17_287_1
  doi: 10.1016/j.bcp.2018.09.007
– ident: e_1_2_17_330_1
  doi: 10.1007/s11910-017-0739-9
– ident: e_1_2_17_9_1
  doi: 10.1038/s41568-019-0205-x
– ident: e_1_2_17_258_1
  doi: 10.1007/s10571-017-0572-3
– ident: e_1_2_17_175_1
  doi: 10.2147/IJN.S299448
– ident: e_1_2_17_195_1
  doi: 10.1021/acs.langmuir.0c01496
– ident: e_1_2_17_132_1
  doi: 10.1080/09205063.2017.1332470
– ident: e_1_2_17_76_1
  doi: 10.1016/j.actbio.2018.04.029
– ident: e_1_2_17_327_1
  doi: 10.1021/acs.analchem.9b02266
– ident: e_1_2_17_105_1
  doi: 10.1007/s10876-020-01955-9
– ident: e_1_2_17_300_1
  doi: 10.3233/JAD-180766
– ident: e_1_2_17_311_1
  doi: 10.1039/C9NR00473D
– ident: e_1_2_17_312_1
  doi: 10.1016/j.nano.2018.09.010
– ident: e_1_2_17_117_1
  doi: 10.1039/C8NA00010G
– ident: e_1_2_17_131_1
  doi: 10.1016/j.jconrel.2021.11.007
– ident: e_1_2_17_233_1
  doi: 10.1021/acsami.8b18664
– ident: e_1_2_17_10_1
  doi: 10.1101/cshperspect.a020412
– volume: 33
  start-page: S85
  year: 2018
  ident: e_1_2_17_80_1
  publication-title: Indian J Nucl Med
– ident: e_1_2_17_194_1
  doi: 10.1208/s12249-017-0812-3
– ident: e_1_2_17_190_1
  doi: 10.1002/anie.201609231
– ident: e_1_2_17_316_1
  doi: 10.1038/nnano.2017.133
– ident: e_1_2_17_347_1
  doi: 10.1007/s13311-016-0448-0
– ident: e_1_2_17_220_1
  doi: 10.1039/C7CS00053G
– ident: e_1_2_17_263_1
  doi: 10.7150/thno.60851
– ident: e_1_2_17_77_1
  doi: 10.1002/adfm.201909369
– volume: 26
  year: 2020
  ident: e_1_2_17_254_1
  publication-title: Med Sci Monit
– ident: e_1_2_17_339_1
  doi: 10.7150/thno.26249
– ident: e_1_2_17_2_1
  doi: 10.1186/s13052-018-0563-0
– ident: e_1_2_17_63_1
  doi: 10.1021/acs.molpharmaceut.0c00461
– ident: e_1_2_17_246_1
  doi: 10.1007/s10571-017-0547-4
– ident: e_1_2_17_305_1
  doi: 10.2147/IJN.S240953
– ident: e_1_2_17_185_1
  doi: 10.15171/apb.2017.002
– ident: e_1_2_17_136_1
  doi: 10.1016/j.jddst.2021.102867
– ident: e_1_2_17_317_1
  doi: 10.1080/10717544.2019.1636420
– ident: e_1_2_17_293_1
  doi: 10.1016/j.radonc.2021.04.021
– ident: e_1_2_17_16_1
  doi: 10.3389/fnins.2018.01019
– ident: e_1_2_17_51_1
  doi: 10.3390/pharmaceutics13010005
– ident: e_1_2_17_157_1
  doi: 10.1021/acsami.7b03504
– ident: e_1_2_17_57_1
  doi: 10.1039/C8DT03948H
– ident: e_1_2_17_101_1
  doi: 10.1021/acs.nanolett.9b02841
– ident: e_1_2_17_14_1
  doi: 10.1016/j.apsb.2020.11.023
– ident: e_1_2_17_98_1
  doi: 10.4103/1735-5362.199041
– ident: e_1_2_17_139_1
  doi: 10.1186/s12951-018-0356-z
– ident: e_1_2_17_324_1
  doi: 10.1016/j.snb.2017.04.101
– ident: e_1_2_17_82_1
  doi: 10.1002/smll.201703115
– ident: e_1_2_17_149_1
  doi: 10.1080/10717544.2017.1402218
– ident: e_1_2_17_304_1
  doi: 10.1016/j.nantod.2020.100965
– ident: e_1_2_17_158_1
  doi: 10.1016/j.pdpdt.2017.12.014
– ident: e_1_2_17_152_1
  doi: 10.3390/magnetochemistry8100131
– ident: e_1_2_17_338_1
  doi: 10.1021/acsanm.2c03936
– ident: e_1_2_17_92_1
  doi: 10.1021/nn501069c
– ident: e_1_2_17_45_1
  doi: 10.1016/j.bcp.2023.115574
– ident: e_1_2_17_68_1
  doi: 10.1186/s12951-020-00751-x
– ident: e_1_2_17_186_1
  doi: 10.1016/j.addr.2021.113851
– ident: e_1_2_17_43_1
  doi: 10.1007/s13239-020-00496-6
– ident: e_1_2_17_187_1
  doi: 10.1371/journal.pone.0179131
– ident: e_1_2_17_191_1
  doi: 10.2147/OTT.S287272
– ident: e_1_2_17_271_1
  doi: 10.1016/j.addr.2022.114536
– ident: e_1_2_17_32_1
  doi: 10.2174/1573409915666191212095340
– ident: e_1_2_17_147_1
  doi: 10.3390/pharmaceutics11020065
– volume: 12
  start-page: 301
  year: 2022
  ident: e_1_2_17_266_1
  publication-title: Biotech
– ident: e_1_2_17_78_1
  doi: 10.1016/j.jconrel.2018.09.015
– ident: e_1_2_17_192_1
  doi: 10.5772/intechopen.68523
– ident: e_1_2_17_291_1
  doi: 10.1016/j.semcancer.2019.10.010
– ident: e_1_2_17_296_1
  doi: 10.1016/j.nano.2018.05.008
– ident: e_1_2_17_122_1
  doi: 10.1038/s41392-021-00724-y
– ident: e_1_2_17_306_1
  doi: 10.1002/adfm.201909529
SSID ssj0017734
Score 2.5698516
SecondaryResourceType review_article
Snippet The blood–brain barrier (BBB) is a tailored system of capillary endothelial cells intermixed with tight junctions and adherent junctions that regulates the...
SourceID proquest
crossref
wiley
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
SubjectTerms Blood-brain barrier
Central nervous system
CNS disorders
drug delivery
Endothelial cells
multifunctional nanotheranostics
nanotechnology
Side effects
Signs and symptoms
Title Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fadfm.202310881
https://www.proquest.com/docview/3051823998
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3JTsMwEIZHqCc4sCMKBfmAxCltFjfLsQWqglSQEJV6ixwvF1CLulw48Q68IU_CTJykLRJCglui2Flsj_3ZmfkNcKFjxAiufAfZIXN41JZoc0Y6JtYqMAZHdUmBwoP7sD_kd6P2aCWK3-pDVAtuZBl5f00GLrJZaykaKpShSHLikziPvSaHLaKix0o_yosi-1s59MjByxuVqo2u31rPvj4qLVFzFVjzEae3A6J8V-to8txczLOmfPsm4_ifj9mF7QJHWce2nz3Y0ON92FoRKTyA2zxGl8Y_u2zIsEO2YVvjSS7yzJB72QOaBD4UczC8xrrkD__5_tGlHShYV0xpY7xDGPZunq76TrEBgyMRKzwnixKhDRKW9JEkFBeRcqWbZL7B61wiTKpER0qYIOCSpOmJF7RHejYeFyoJjqA2noz1MbCERwbJMotlEHLj6kSQ-ypOj5QbaunpOjhlBaSyUCenTTJeUqur7KdURGlVRHW4rNK_Wl2OH1M2yvpMC_ucpdjL4cQK4Syug59XzC93STvXvUF1dvKXTKewicfceks2oDafLvQZEs08O89b7RdcG-0Z
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1LT8JAEMc3Bg_qwbcRRd2DiadCHwttj6ASUMDEQMJt0-7joikG4eLJ7-A39JM4020LmBgTPbbd7Ws7u7_dzvyHkEsVAEYw6VrADrHF_LoAm9PC0oGSntYwqgsMFO4PGp0RuxvXc29CjIUx-hDFghtaRtpfo4HjgnRtoRoaSY2h5AgoAQZfr2Na73RW9VgoSDm-b34sNxx08XLGuW6j7dZW66-OSwvYXEbWdMxp75A4v1vjavJUnc_iqnj7JuT4r8fZJdsZkdKm-YT2yJpK9snWkk7hAemmYbo4BJqVQwp9soncSiapzjMF9KUPYBVwVahB4RhtoUv85_tHC5NQ0FY0xdx4h2TUvh1ed6wsB4MlgCwcK_bDSGmALOECTEgW-dIWdhi7Go4zATwpQ-XLSHseE6hOj8igHJS0cVgkQ--IlJJJoo4JDZmvAS7jQHgNpm0VRujBCjMkaTeUcFSZWHkLcJEJlGOejGdupJVdjq-IF6-oTK6K8i9GmuPHkpW8QXlmoq8cOjqYWwGfBWXipi3zy1l486bdL7ZO_lLpgmx0hv0e73UH96dkE_Yz4zxZIaXZdK7OAHBm8Xn6CX8BOuzxNA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3JTsMwEIYtBBKCAzuiUCAHJE5ps7hZji0laoEWhKjUm5V4uYDSqrQXTrwDb8iTMBMnaYuEkOCYxM5ie-zPzsxvQi5kABhBhWMCOyQm9RscbE5xUwVSuErBqM4xULjX9zoDejNsDBei-LU-RLnghpaR9ddo4GOh6nPR0FgojCRHPgkw9nqNelaA7br9WApI2b6v_yt7Nnp42cNCttFy6sv5l4elOWsuEms25ETbJC5eVnuaPNdm06TG377pOP7na3bIVs6jRlM3oF2yItM9srmgUrhPulmQLg6Aet3QgB5Zx22lo0zl2QDwNe7BJuChkMOAa0YLHeI_3z9auAWF0YonuDPeARlE109XHTPfgcHkwBW2mfhhLBUgFncAJQSNfWFxK0wcBdcpB5oUofRFrFyXctSmR2CQNgra2DQWoXtIVtNRKo-IEVJfAVomAXc9qiwZxui_CvMjYXmS27JCzKICGM_lyXGXjBemhZUdhkXEyiKqkMsy_VgLc_yYslrUJ8sN9JVBNwczK6CzoEKcrGJ-uQtrtqNeeXT8l0znZP2hHbG7bv_2hGzAaao9J6tkdTqZyVOgm2lyljXgL4aI7-w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multifunctional+Nanotheranostics+for+Overcoming+the+Blood%E2%80%93Brain+Barrier&rft.jtitle=Advanced+functional+materials&rft.au=Beygi%2C+Mohammad&rft.au=Oroojalian%2C+Fatemeh&rft.au=Azizi%E2%80%90Arani%2C+Soheil&rft.au=Hosseini%2C+Seyed+Samad&rft.date=2024-05-01&rft.issn=1616-301X&rft.eissn=1616-3028&rft.volume=34&rft.issue=19&rft_id=info:doi/10.1002%2Fadfm.202310881&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_adfm_202310881
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1616-301X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1616-301X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1616-301X&client=summon